Quarterlytics / Healthcare / Medical - Healthcare Information Services / TALi Digital Limited

TALi Digital Limited

td1 · ASX Healthcare
Claim this profile
Ticker td1
Exchange ASX
Sector Healthcare
Industry Medical - Healthcare Information Services
Employees 11-50
← All annual reports
FY2021 Annual Report · TALi Digital Limited
Sign in to download
Loading PDF…
Annual Report
2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contents

Corporate Directory 

Chairman’s Report 

Chief Executive Officer’s Report 

Directors’ Report 

Remuneration Report 

Auditor’s Independence Declaration 

Consolidated Statement of Profit or Loss and Other Comprehensive Income 

Consolidated Statement of Financial Position 

Consolidated Statement of Changes in Equity 

Consolidated Statement of Cash Flows 

Notes to the Financial Statements 

Directors’ Declaration 

Independent auditor’s review report to the members of TALi Digital Limited 

Corporate Governance Statement 

Shareholder Information 

3

4

6

8

17

28

29

30

31

33

34

64

66

69

70

2  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate Directory

Directors 

Ms Sue MacLeman

Mr Jefferson Harcourt

Dr David Brookes

Mr Glenn Smith

Company secretary 

Mr Stephen Denaro

Registered office 

Level 5,

19 William Street

Cremorne, Victoria 3121

Principal place of business 

Level 5,

Share register 

19 William Street

Cremorne, Victoria 3121

Automic Registry Services

Level 3, 50 Holt Street

Surry Hills, New South Wales 2010 Australia

Telephone: 1300 288 664

Website: automic.com.au

Email: hello@automic.com.au

Auditor 

Grant Thornton Audit Pty Ltd

Collins Square, Tower 5

727 Collins Street

Melbourne VIC 3000

Stock exchange listing 

  TALi Digital Limited shares are listed on the

Australian Securities Exchange.

ASX code 

TD1

Website 

www.talidigital.com

TALi Digital Limited Annual Report 2021  |  3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Times Group is the largest media conglomerate in 
India and engages with 550 million people each month 
via various social networking applications. Whilst the 
planned direct-to-consumer roll-out of TALi in this market 
via the Times Group has commenced, the initial timeframes 
targeted were hampered by the COVID-19 surge in this 
region earlier this year. We do remain confident of the 
potential for TALi’s products in this large addressable 
market and will update shareholders of our progress 
once the full marketing launch occurs later in the year.

We have continued to invest in our IP portfolio throughout 
the period and have strengthened our position in line 
with our global channel partner strategy. During the 
year we were granted our first patent in Japan, with this 
attractive region being the world’s third largest market for 
ADHD treatments and growing at more than 20 percent 
annually. We also further strengthened our IP position in 
China and Australia. It is TALi’s patents and trademarks 
across multiple jurisdictions, including the US, that we 
see as pivotal in delivering international partnerships, 
and firmly places our Company at the centre of the 
digital therapeutics ecosystem.

From a financial perspective, our Balance Sheet is solid 
and we have sufficient funding to execute our global 
partnership growth plans. During FY21, we conducted a 
successful capital raise of $3.85m and welcomed a range 
of new institutional investors onto our share register as well 
as recognised the continued support from existing holders.

Strengthened Advisory Board

During the year we welcomed the contributions from our 
new Advisory Board members Ms Sarah Michel, Dr Phil 
Lambert, Professor Con Stough and Dr Scott Collins. The 
Advisory Board has been instrumental in guiding our 
scientific programs and supporting the team as we begin 
to scale in major global markets. Their expertise and 
deep experience is highly valuable as we commercialise 
our digital therapeutic platform and I look forward to 
their ongoing contribution in FY22.

Chairman’s Report

Dear Shareholders,

I am pleased to present TALi Digital’s Annual Report for 
the 2021 financial year.

The past 12-months have been transformative for our 
Company as we have executed a number of important 
milestones on our path toward commercialisation of 
our TALi technology platform in key global markets. 
Inattention and cognitive impairment right across all 
ages continues to be a globally growing diagnosis, 
and solutions outside of traditional pharmacological 
treatments are growing rapidly, underpinning our 
Company’s goal to usher in the next generation of  
digital health solutions.

Executing on global growth strategy

During the year our team remained dedicated to 
executing on our global growth plans. We recently 
announced a landmark deal for our Company, executing 
a Strategic Licensing Agreement with global leader Akili 
Interactive Labs, Inc. (Akili). Under the agreement, Akili 
has become the exclusive commercialisation partner for 
TALi paediatric cognition products in the US market. 
Under the agreement TALi will receive milestone payments 
and royalties upon satisfaction of agreed outcomes.

Akili is a global leader in digital therapeutics having 
commercialised the first FDA-cleared and CE-marked 
video game treatment to improve attention in children 
ages 8–12 years with Attention Deficit Hyperactivity 
Disorder (ADHD). In this regard, Akili and TALi’s 
technologies are highly complementary and now cover 
the full age-range in children, given TALi’s technology 
is clinically validated and designed to target and 
improve attention in the early childhood years of those 
aged 3–8. Importantly, both Akili and TALi also have a 
shared focus on rigorous clinical validation and high-
end user experience, and are committed to changing 
the way people think about medicine and the role digital 
therapeutics can play in healthcare.

To execute an exclusive partnership with a group of 
the calibre of Akili also validates the market potential 
of the TALi technology and provides the foundation for 
additional global partnerships in other regions, a key 
area of strategic focus for our Company in the year ahead.

Earlier in the period we also announced a partnership 
for the Indian market, executing an investment and 
advertising agreement with Brand Capital International, 
the strategic investment arm of The Times Group. 

4  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We are in the early stages of our global expansion 
journey with our recent US licensing agreement putting 
us in a good position to progress developments in other 
markets. These opportunities underline the potential for 
long term sustainable revenues, ensuring the Company 
is well positioned to deliver value for shareholders in the 
coming years.

I would particularly like to thank our team for their hard 
work and efforts during these difficult and challenging 
times. I would also like to thank my fellow Directors for their 
guidance and insights throughout the year. And to our 
shareholders, thank you for your continued support and I 
look forward to updating you on our progress as we head 
into a new and exciting financial year for our Company.

Yours sincerely,

Sue MacLeman 
Chair

TALi Digital Limited Annual Report 2021  |  5
TALi Digital Limited Annual Report 2021  |  5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chief Executive Officer’s Report

Clinical development and trials collecting US based 
paediatric data will be facilitated by Duke Clinical 
Research Institute (DCRI). DCRI and TALi have an existing 
collaboration and protocols for the trials are currently 
being prepared by DCRI. Trial commencement is 
projected to occur this calendar year. The next stage will 
be for TALi to follow a submission process with the FDA.

Once cleared, TALi’s technology platform has the 
potential to lead to a multi-decade annuity revenue 
stream in the US market as no additional regulatory 
approvals in the US will be required for this paediatric 
ADHD product (based on current US legislation/
regulations). First sale and subsequent revenue 
milestones will be paid from Akili to TALi on revenues 
targets being achieved. Royalty payments will be paid on 
all sales of the TALi products in the US market on-top of 
milestone payments.

India market penetration

In December 2020, TALi announced that it had signed 
an investment and advertising agreement with Brand 
Capital International (BCI), the strategic arm of Bennett, 
Coleman and Company Ltd. (The Times Group), to 
facilitate TALI’s entry and growth in the strategically 
important Indian market. 

As part of the agreement, The Times Group invested 
US$2 million in TALi to provide funds for our Company 
to accelerate the roll out of products in India. These 
funds have been deployed towards TALi’s marketing 
communication in the Indian market through the Times 
Group’s media assets, to allow TALi to grow its direct-to- 
consumer reach. 

Since TALi DETECT and TALi TRAIN were made available 
via the iOS and Android app stores the initial consumer 
engagement has been strong, with over 25,000 
downloads from the Google Play store.  The full ‘live-
launch’ of the TALi apps and the full roll out of the print 
and radio campaigns is scheduled for later in 2021, given 
the surge in COVID-19 cases throughout India earlier this 
year. India remains a very relevant market for TALi with a 
direct opportunity of approximately 30 million children in 
the TALi age range.

Dear Shareholders,

During 2021 we were keenly focused on broadening the 
reach of our TALi platform in a range of markets and 
progressing our global partnership growth strategy and  
I am very pleased to report we delivered on several 
major milestones over the past year, including entry into 
the US and Indian markets.  

OPERATIONAL REVIEW

Strategic licensing agreement with Akili Interactive for 
large and growing US-market

On 18 August 2021, TALi announced it had entered into a 
Strategic Licensing Agreement with Akili Interactive Labs, 
Inc. (Akili), a global leader in the digital therapeutics 
space. Under the Agreement, our Company will receive 
total future contingent milestone payments  of A$51M 
(US$37.5M)1 as well as royalties on future sales. Akili now 
holds a licence for TALi’s market leading technology to 
become the exclusive commercialisation partner for all 
paediatric cognition products in the US.

This Agreement is transformational and highly strategic 
for TALi. Not only is the Attention Deficit Hyperactivity 
Disorder (ADHD) treatment market in the US the largest in 
the world (with an estimated value of US$10B annually), 
it also provides significant validation for our technology 
given Akili is a global leader in this field. Akili has 
commercialised the first FDA-cleared and CE-marked 
video game treatment, EndeavorRx®, as a Prescription 
Digital Therapeutic (“PDT”) to improve attention function 
in children with ADHD.  Akili are also backed by leading 
investment houses and pharmaceutical companies, 
having recently completed a US$160M funding round 
led by top-tier global investment management group, 
Neuberger Berman Funds.

TALi’s platform builds on Akili’s product portfolio and 
complements it flagship product EndeavorRx®, which 
targets children with ADHD aged between 8–12 years. 
Together Akili and TALi’s technology platforms will now 
cover the age spectrum of childhood from 3–12 years.

The Agreement is also structured to leverage each 
organisation’s expertise. TALi will lead the clinical and 
regulatory clearance process, while Akili will lead 
commercialisation of the approved paediatric digital 
solutions in the United States. The initial milestone 
payment to TALi will be US$2m upon FDA clearance. 
TALi will also receive payments from Akili for clinical 
development in addition to the milestone payments.

1 Exchange rate as at 18th August 2021

6  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enhanced IP portfolio protection

Positive outlook for FY22

In FY22, the focus is on further progressing the Company’s 
partnership growth strategy. Commercial discussions 
are ongoing with potential partners in Japan and South 
Korea and if successful these are expected to position 
TALi to generate additional value from our clinically-
validated technology platform. These discussions also 
support TALi in its broader goal to build sustainable long-
term recurring revenues from key global target markets.

TALi is also currently engaged in a evaluating a research 
program exploring the potential for its technology 
platform to be expanded to other cognitive decline 
indications, more common in populations with Mild 
Cognitive Impairment (MCI). MCI has been found to often 
been a precursor to recognising Alzheimer’s disease and 
other forms of dementia. Many conditions associated 
with MCI are not able to be screened with conventional 
imaging, such as MRI scan, and require a functional test 
to assess the reduction in executive cognitive function.  

Finally, I would like to thank our shareholders for 
your continued commitment, and we look forward to 
delivering further strategic milestones in the year ahead. 

Yours sincerely,

Glenn Smith 
Managing Director

TALi’s IP portfolio was further strengthened in FY21,  
with the granting of its first Japanese patent by the Japan 
Patent Office. The patent has an expiry date of March 31, 
2035 and the claims of the patent cover the TALi DETECT® 
and TALi TRAIN® products. This represents a significant 
market opportunity given non-pharmaceutical based 
approaches are preferred treatment methods in this region.

TALi was also recently issued trademark coverage in 
China from the China Trade Mark Office in relation to its 
core TALi TRAIN® and TALi DETECT® products.  
This trademark has been classified under Acceptance 
Class 10 — a category that includes goods for surgical, 
medical, dental and veterinary purposes.

In July 2021, TALi was granted its first Australian patent 
by IP Australia. This patent covers TALi TRAIN® and TALi 
DETECT® as well as next generation solutions currently in 
development, and has a continuance period of 20-years 
from the priority date March 31, 2015.

Australian market update

TALi is currently focused on further raising awareness 
of its products in the healthcare market in Australia 
and continues to make developments to enhance the 
user experience between consumers and healthcare 
professionals. During the period, the Company initiated a 
shift towards seeking reimbursement for the TALi solution, 
which initially focuses on market data collection as 
opposed to direct revenue generation. 

Compiling a strong set of data will help us to progress 
plans such as the undertaking of a reimbursement 
submission (MSAC and/or PBS submission) for TALi to be 
potentially listed on the Medicare Benefits Scheme (or 
other relevant scheme) in Australia as a reimbursable 
diagnostic aid and therapeutic. 

Financial position

The Company’s cash at bank as at 30 June 2021 was 
$2.7 million, allowing the Company to continue to pursue 
growth via its global partnership model. In February 
we received strong support from new and existing 
shareholders raising $3.85 million, with funds raised 
partly used to support TALi’s recent entry into the  
US-market via its Agreement with Akili.

The Company reports total revenue and income of 
$548,905 and a net loss of $4,858,273 for the period. 
Operating, financing and investing activities incurred a 
net cash outflow for the year of $1,202,457.

TALi Digital Limited Annual Report 2021  |  7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Report

FOR THE YEAR ENDED 30 JUNE 2021

The directors present their report, together with the financial statements, on the consolidated entity (referred to 
hereafter as the ‘Group’) consisting of TALi Digital Limited (referred to hereafter as the ‘Company’ or ‘parent entity’) 
and the entities it controlled at the end of, or during, the period ended 30 June 2021.

Directors

The following persons were directors of TALi Digital Limited during the whole of the financial year and up to the 
date of this report, unless otherwise stated:

Name and independence status

Period of office and special responsibilities

Sue MacLeman 
Independent Non-Executive Director & Chair

Appointed September 6, 2018 Director and Chair since 
September 6, 2018. Member of the Audit Committee.

Jefferson Harcourt 
Non-Executive Director

David Brookes 
Non-Executive Director

Glenn Smith 
Managing Director

Appointed February 25, 2016. Member of the Audit 
Committee.

Appointed on June 29, 2020. Simultaneously Dr Brookes 
was appointed the Chair of the Audit Committee.

Appointed Chief Executive Officer October 3, 2017 and 
appointed Managing Director May 10, 2018.

8  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Principal activities

INDIAN MARKET PARTNERSHIP & ROLLOUT

TALi [TALi Digital Limited (ASX: TD1)] is a digital health 
company delivering diagnostic and therapeutic solutions 
for cognitive function and behaviour. The Company has 
built a platform technology, the first iteration of which 
targets cognitive attention skills during early childhood 
through its breakthrough evidence a video-gamed-based 
TALi screening (‘DETECT’) and training (‘TRAIN’). This 
first to market and user experience focused technology 
is complementary to existing diagnosis and therapy 
placing TALi at the forefront of patient experience and 
early intervention thus positioning the business as an ideal 
partner in the global digital health sector. 

Innovations that target cognitive skills to deliver non-
invasive early interventions underpin the TALi platform 
technology. This innovation focus is allowing the Company 
to deliver a series of product developments in ADHD 
(Attention Deficit Hyperactivity Disorder) and ASD (Autism 
Spectrum Disorder) for predictive diagnosis and treatment 
for all age groups along with a core research program 
exploring applications for populations afflicted with 
Mild Cognitive Decline (MCI has been found to often 
been a precursor to recognizing Alzheimer’s disease and 
other forms of dementia). TALi solutions aim to deliver 
foundational advances in human cognitive function and 
behaviour only dreamt of a few short years ago. 

TALi is incorporated and domiciled in Australia, and with 
a registered office and principal place of business located 
at Level 5, 19 William Street, Cremorne Vic 3121. Except as 
disclosed elsewhere in this Report, there have been no 
significant changes in the nature of these activities during 
the year.

Operating and financial review 

STRATEGIC LICENCING AGREEMENT WITH AKILI

During FY21 TALi made significant progress toward the 
progression of its global partnership strategy, delivering 
on several key milestones and subsequent to the reporting 
period announcing a Strategic Licensing Agreement 
(Agreement) for paediatric cognition products in the US 
market with Akili Interactive Labs, Inc. (Akili). Post the 
period an agreement was entered into by the parties (see 
ASX announcement on 18 August 2021) under which TALi 
will receive $51 million (US$37.5 million) in total future 
contingent milestone payments plus royalties on potential 
revenues.

This Agreement is transformational and highly strategic 
for the Group given the paediatric cognitive treatment 
market in the US is the largest in the world. In addition, 
the Agreement provides significant validation for the 
Group’s technology platform and is expected to provide 
the foundation for partnerships in other regions.

In December 2020, the Company executed an investment 
and advertising agreement with Brand Capital International 
(BCI), the strategic arm of Bennett, Coleman and 
Company Ltd. (The Times Group), to facilitate TALI’s entry 
and growth into the strategically important Indian market. 

As part of the agreement, The Times Group invested US$2 
million in the Company to provide funds for the Group to 
accelerate the roll out of products in India. These funds 
have been deployed towards the Group’s marketing 
and advertising program in the Indian market through 
the Times Group’s media assets, to allow TALi to grow its 
direct-to-consumer reach. 

Soft-launch activities commenced in the Indian market 
in April and since this time initial consumer engagement 
with TALi products has been strong, with over 25,000 
downloads from the Google Play store. The full ‘live-
launch’ of the TALi apps and the full roll-out of the print 
and radio campaigns has been delayed and is scheduled 
for later in 2021, given the surge in COVID-19 cases 
throughout India earlier this year. 

AUSTRALIAN MARKET UPDATE

Over the 2021 financial year, the Group initiated a shift 
towards seeking reimbursement for the TALi solution, 
which initially focuses on market data collection as 
opposed to direct revenue generation in order to build a 
more sustainable and longer-term revenue stream. 

Compiling a strong set of data is expected to help progress 
plans such as the undertaking of a reimbursement 
submission (Medicare Benefits Scheme [MBS] and/or 
Pharmaceutical Benefits Scheme [PBS]) for TALi to be 
potentially listed on the MBS and/or PBS in Australia. The 
Company expects real world data collected from its initial 
Australia roll-out combined with clinical development data 
from trials undertaken by Duke Clinical Research Institute 
in the US, under its Agreement with Akili, to support the 
Australian market process.

FINANCIAL REVIEW

The statement of profit or loss and other comprehensive 
income shows a loss of $4,858,273 (2020: $3,397,938) 
for the year. The Group has no bank debt. As at 30 June 
2021 the Group had a cash position of $2,726,518 (2020: 
$3,945,408). Operating, financing and investing activities 
incurred a net cash outflow for the year of $1,202,457 
(2020: inflow $3,603,974).

Advertising and promotion expenses for the year ended 
30 June 2021 were $885,247 (2020: $342,132) with the 
increase largely associated with the Group’s soft-launch 
entry into the Indian market via its advertising agreement 
with The Times Group. As at 30 June 2021 the Group has 

TALi Digital Limited Annual Report 2021  |  9

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Report continued

FOR THE YEAR ENDED 30 JUNE 2021

$1,973,180 in prepaid advertising credits with The Times 
Group, which will be utilised as the Group executes it’s 
Indian advertising and marketing plan.

The Group continues to pursue non-dilutive funding 
including government funded incentive programs such 
as the R&D Tax Incentive (RDTI) and the Export Market 
Development Grant (EMDG). At 30 June 2021 the Group 
has a receivable for the estimated RDTI refund for the year 
ended 30 June 2021 of $795,874 (2020: $682,348) and 
during the year the Group received an EMDG of $100,000 
(2020: nil). 

During the year the Group received $50,000 (2020: 
$50,000) of COVID-19 related government PAYGW cash 
booster payments. This $50,000 was recorded as income 
in FY20. The Group also received $171,000 of JobKeeper 
cash payments (2020: $87,000). Of the $171,000, $42,000 
was recorded as income in FY20.

COVID-19

The Company highlights that the impact of the COVID-19 
pandemic and associated measures (e.g., travel 
restrictions, lockdowns, remote work and social distancing) 
has been of a significant nature to the operations of TALi. 
This has been reflected in the delayed timing of execution 
of the agreement between TALi and Akili to progress 
the medical use of the TALi technology. Similarly, the 
rescheduling of launch activities for the non-medical use 
(consumer and education channels) of the TALi technology 
in India has been necessary. 

OUTLOOK

In FY22, TALi is focused on progressing the Group’s 
partnership growth strategy. Commercial discussions are 
ongoing with potential partners in a range of international 
markets including Japan and South Korea. 

This ongoing work, as well as the commencement of Akili 
partnership activities such as the clinical development 
program in the current calendar year, ensures the Group is 
well positioned to progress its growth strategy.

TALi Health Pty Ltd

TALi Health, (100% owned subsidiary of TALi Digital 
Limited) is a digital health company pioneering 
development of software solutions to address 
neurological conditions in early childhood. Backed by 
over 25 years of research, the TALi platform is a scientific 
and clinically validated program that addresses the 
world’s leading early childhood issue—inattention, 
a key feature in conditions including Attention Deficit 
Hyperactivity Disorder (ADHD) and Autism Spectrum 
Disorder (ASD). Our team of neuroscientists, developers 
and designers are on a mission to strengthen the 
attention of children globally to deliver a lasting social 
impact.

At TALi, happier kids start here. Approximately 136 million 
children globally have severe attention difficulties. 
The key to better outcomes for children with attention 
difficulties is early identification and intervention. 
Currently, there is a significant lack of tools available to 
parents, teachers and healthcare professional to provide 
effective assessment and treatment. Consequently, 
many children who have attention difficulties remain 
undetected and miss out on life-changing interventions. 
TALi DETECT and TALi TRAIN as early assessment and 
training programs are early intervention programs 
designed to change that.

TALi focuses on assessing potential attention issues 
and then if required strengthening underlying 
attentional processes at the cognitive level. Thus, TALi 
has the potential to promote deeper and more stable 
improvements in attention, as well as behavioural 
symptoms of attention (e.g. inattentive and hyperactive 
behaviour), without the negative side effects associated 
with psychostimulant medication. As a digital health 
solution TALi provides logistical advantages over 
traditional face to face intervention methods to deliver 
health care into the home providing significant cost 
savings and better outcomes for children.

10  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Capital and corporate structure

On 8 December 2020 the Company announced an investment of $2.7million ($2million USD) by Brand Capital 
International (BCI), the strategic investment arm of Bennett, Coleman and Company Ltd (the Times Group). On 6 
January 2021 the Company issued 81,800,594 shares at $0.033 per share.

On 16 February 2021 the Company announced a Placement to raise $3.85million before costs and a proposed issuance 
of options to Placement participants and to the Sole Lead Manager. Subject to shareholder approval, the Company will 
issue one free attaching option for every 2 new shares purchased in the Placement. The attaching options will have an 
exercise price of $0.09 per share and will expire 12 months after the date of issue. In addition, Subject to shareholder 
approval, the Company also proposed to issue the following options to Taylor Collison (as Sole Lead Manager on the 
Placement or its nominee): 

(a) 5 million options with exercise price of $0.09 per share and expiring 18 months after completion of the Placement;

(b) 5 million options with exercise price of $0.12 per share and expiring 24 months after completion of the Placement;

(c) 5 million options with exercise price of $0.15 per share and expiring 24 months after completion of the Placement.

On 22 February 2021 the Company issued 98,717,948 ordinary shares at $0.039 per share. 

On 30 June 2021 the Company issued 2,082,029 Ordinary shares upon exercise of unlisted options.

Full details of movements in share capital for the year are detailed in note 20 to the financial statements.

Unissued shares 

Details of unissued Ordinary Shares, interests under options as at the date of this report are as follows:

Number of options on issue at the date of this report

Exercise price when granted

Expiry date

Director options:

Vendor, broker & 
consultant options:

Employee options:

13,600,000

22,500,000

7,188,883

10,200,000

2,100,000

Total 55,588,883

$0.030

$0.030

$0.090

$0.030

21 November 2022

24 November 2025

30 June 2022

21 November 2022

$0.015

31 October 2024

On 22 February 2021, 49,358,974 options were provisionally issued to shareholders that participated in the placement 
and 15,000,000 options were provisionally issued to the Broker of the placement. The options were provisionally issued 
as they are required to be approved by shareholders at a shareholder meeting. 

TALi Digital Limited Annual Report 2021  |  11

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Report continued

FOR THE YEAR ENDED 30 JUNE 2021

Directors’ qualifications, experience and responsibilities

The directors of the Company at any time during the year or since the end of the financial year are as follows.
Directors were in office for the entire period unless stated otherwise:

Name, qualification and 
independence status

Experience, special responsibilities and 
other directorships

Ms Sue MacLeman 
Independent Non-Executive 
Director & Chair 
Qualifications: BPharm. 
MMktg, MLaw, FTSE

Ms S MacLeman joined the Board on 6 September 2018. She has been a Director 
and Chair since 6 September 2018 and is a member of the Audit Committee.

Ms S MacLeman has over 30 years’ experience in the medtech, pharma and 
biotech sector and is currently the Chair of MTPConnect (Medical Technology 
and Pharmaceuticals Industry Innovation Growth Centre MTPII-GC Ltd), Chair of 
Tali Digital Ltd (ASX:TD1), Non-Executive Director of Palla Pharma Ltd (ASX:PAL), 
Non-Executive Director at Anatara Lifesciences Ltd (ASX:ANR), Non-Executive 
Director of Planet Innovation Holdings Ltd and Non-Executive Director of Omico.

Mr Jefferson Harcourt 
Non-Executive Director  
Qualifications: B.Eng (Hons) 
GAICD

Mr J Harcourt joined the Board on 25 February 2016. He is a Non-Executive 
Director of the Company and is a member of the TALi Digital Audit Committee. 
Mr Harcourt oversaw the initial development of TALi and his extensive 
product development and commercial expertise will assist the Company in 
commercialising the technology.

Mr J Harcourt sits on a number of private technology company boards in the 
medical device and security markets.

Mr Glenn Smith 
Managing Director 
Qualifications: MBA, BA (Econ)

Mr G Smith was appointed Chief Executive Officer on 3 October, 2017 and 
appointed Managing Director on 10 May, 2018. He has over twenty years’ 
experience in leading customer-centric businesses in periods of rapid growth.

Mr G Smith sits on a number of private technology company boards and is a 
Non-Executive Director of HitIQ Limited (ASX:HIQ).

Dr David Brookes 
Independent Non-Executive 
Director 
Qualifications: MBBS, 
FACRRM, FAICD

Dr D Brookes was appointed on 29 June 2020. Simultaneously Dr Brookes was 
appointed the chair of the audit committee. Dr Brookes has extensive experience 
in the health and biotechnology industries and held Board positions in a number 
of ASX listed biotechnology companies, including as Chairman of genomics 
solutions company, RHS Ltd, which was acquired by PerkinElmer Inc (NYSE:PKI) 
in June 2018. He is currently the Non-Executive Chairman of Anatara Therapeutics 
Ltd (ASX: ANR) and of Factor Therapeutics Ltd (ASX:FTT), and a Non-Executive 
Director of Island Pharmaceuticals Limited (ASX:ILA). He was the Non-Executive 
Chairman of the unlisted Better Medical Group until that company was acquired 
by private equity firm Livingbridge in January 2021.

Dr. Brookes maintains roles as a clinician and as a biotechnology industry consultant. 
Dr Brookes, MBBS (Adelaide), is a Fellow of the Australian College of Rural and 
Remote Medicine and a Fellow of the Australian Institute of Company Directors.

12  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Company secretary

Mr Stephen Denaro BCom, CA, MAICD, Grad Dip Corp Gov, AGIA

Mr Denaro was appointed as Company Secretary of TALi Digital Limited on 21 February 2019. He has over 30 years 
of senior financial, administrative, commercial and company secretarial experience with ASX listed companies.

Directors’ interests

The relevant interest of each director in the share capital of the Company, as notified by the Company to the ASX in 
accordance with S205G (1) of the Corporations Act 2001, as at the date of this report is as follows:

Director

Ms S MacLeman

Dr D Brookes

Mr J Harcourt

Mr G Smith

Number of  
ordinary shares

Number of options  
to acquire ordinary shares

505,920

3,000,000

38,688,423

1,454,546

6,800,000

3,400,000

3,400,000

22,500,000

Directors’ meetings and committee membership

Due to the small number of non-executive directors on the Board, all the incumbent non-executive directors are 
members of the Audit Committee. The Audit Committee considers quality and reliability of financial information 
prepared for use by the Board in determining policies or for inclusion in the financial report. The Company’s 
Remuneration and Nomination Committee was disbanded on 1 July 2016 and the responsibility for the composition 
of the Board and nomination of new directors and reviewing and monitoring the performance of for directors, 
executive and staff remuneration is now assumed by the full Board.

The number of directors’ meetings (including meetings of committees of directors) and number of meetings 
attended by each of the directors of the Company during the financial year are:

Director

Ms S MacLeman

Mr J Harcourt

Mr G Smith

Dr D Brookes

Board meetings

Audit committee meetings 

Attended

Held1

Attended

Held1

12

12

12

12

12

12

12

12

2

2

2

2

2

2

2

2

1 Held: represents the number of meetings held during the time the director held office.

TALi Digital Limited Annual Report 2021  |  13

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Report continued

FOR THE YEAR ENDED 30 JUNE 2021

Dividends

The directors do not recommend a dividend be paid or 
declared by the Company for the year. No dividend has 
been paid by the Company since its incorporation on 7 
April 2004.

Significant changes in the state of affairs

There were no significant changes in the state of affairs 
of the Group during the financial year.

Environmental regulation

The Group’s operations are not subject to any significant 
environmental regulations under either Commonwealth 
or State legislation. The directors believe that the Group 
has adequate systems in place for the management of 
its environmental requirements and are not aware of 
any breach of those environmental requirements as they 
apply to the Group.

Events subsequent to reporting date

On 20 July 2021, 6,000,000 options were issued to 
employees under the employee incentive scheme.

On 20 July 2021, 900,000 options previously issued to 
employees were cancelled.

On 18 August 2021, the Company announced it 
had entered into a Strategic Licensing Agreement 
(Agreement) with Akili Interactive Labs, Inc., a global 
leader in the digital therapeutics space. Under the 
Agreement, the Company will receive total milestone 
payments of up A$51 million (US$37.5 million) as well as 
royalties on future sales.

On 28 September 2021 the Company received the FY21 
income tax return refund of $795,873 in relation to the 
Research & Development Tax Incentive. 

In the interval between the end of the financial year 
and the date of this report no other item, transaction or 
event of a material and unusual nature has arisen other 
than outlined in this section that is likely, in the opinion of 
the directors of the Company, to affect significantly the 
operations of the Group, the results of those operations, 
or the state of affairs of the Group in future financial years.

insurance that extends to former directors. The indemnity 
provided by the Company is an unlimited and continuing 
indemnity irrespective of whether a director ceases to 
hold any position in the Company.

Insurance Premiums

Since the end of the financial year, the Company has 
paid a premium for Directors’ and Officers’ Liability 
insurance for current and former directors and officers, 
including executive officers of the Company. The directors 
have not contributed to the payment of the policy premium.

The Directors’ and Officers’ Liability insurance policy 
covers the directors and officers of the Company 
against loss arising from any claims made against them 
during the period of insurance (including company 
reimbursement) by reason of any wrongful act committed 
or alleged to have been committed by them in their 
capacity as directors or officers of the Company and 
reported to the insurers during the policy period or if 
exercised, the extended reporting period.

Risk management

The Group takes a proactive approach to risk 
management. The Board is responsible for ensuring that 
risks, and also opportunities, are identified on a timely 
basis and that the Group’s objectives and activities are 
aligned with the risks and opportunities identified by the 
Board. The Group believes that it is crucial for all Board 
members to be a part of this process, and as such the 
Board has not established a separate risk management 
committee. Instead sub-committees are convened as 
appropriate in response to issues and risks identified by 
the Board as a whole, and each respective subcommittee 
further examines the issue and reports back to the Board.

The Board has a number of mechanisms in place to 
ensure that management’s objectives and activities are 
aligned with the risks identified by the Board. These 
include the following:

•   Implementation of Board approved strategic and 

operating plans and budgets and Board monitoring 
of progress against these plans, budgets, including 
the establishment and monitoring of KPIs of both a 
financial and non-financial nature.

Indemnification and insurance of officers

•   The establishment of committees to report on 

Indemnification

The Company has agreed to indemnify the directors 
of the Company against liability arising as a result of 
a director acting as a director or other officer of the 
Company. The indemnity includes a right to require the 
Company to maintain Directors’ and Officers’ Liability 

specific business risks.

The Audit Committee assists in discharging the Board’s 
responsibility to manage the organisation’s risks, and 
monitors Management’s actions to ensure they are in line 
with Group policy.

14  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rounding off

The Group is of a kind referred to in ASIC Corporations 
(Rounding in Financial/Directors’ Report) Instrument 
2016/191 issued by the Australian Securities and 
Investments Commission (ASIC), relating to the rounding 
off of amounts in the consolidated financial statements. 
Amounts in the consolidated financial statements have 
been rounded off in accordance with that legislative 
instrument to the nearest dollar, unless specifically stated 
to be otherwise.

Lead Auditor’s Independence Declaration under Section 
307C of the Corporations Act 2001

The lead auditor’s independence declaration forms part 
of the Directors’ Report for the year ended 30 June 2021 
and is set out after the Directors’ report.

Non-audit services 

Details of amounts paid or payable to the auditor for 
non-audit services provided during the year by the 
auditor are outlined in note 26 to the financial statements. 
In the event non-audit services are provided by the 
auditor, the Board has established procedures to ensure 
that the provision of non-audit services is compatible with 
the general standard of independence for auditors.

These include:

•   All non-audit services are reviewed and approved 
to ensure that they do not impact the integrity and 
objectivity of the auditor; and

•   Non-audit services do not undermine the general 
principles relating to auditor independence as 
set out in APES 110 ‘Code of Ethics for Professional 
Accountants’ issued by the Accounting Professional 
& Ethical Standards Board, including reviewing 
or auditing the auditor’s own work, acting in a 
management or decision-making capacity for the 
Group, acting as advocate for the Group or jointly 
sharing economic risks and rewards.

TALi Digital Limited Annual Report 2021  |  15

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TALi Digital Limited Annual Report 2021  |  16
16  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remuneration Report — AUDITED

FOR THE YEAR ENDED 30 JUNE 2021

This report outlines the compensation arrangements in place for Non-Executive Directors 
(NEDs) and senior executives of the Group being the Key Management Personnel (KMP) of the 
Group – being those persons having authority and responsibility for planning, directing and 
controlling the major activities of the Group, directly or indirectly, including any director and 
includes all the executives in the Group.

For the purposes of this report, the term “executive” 
includes the senior executives but does not include 
the NEDs or the secretary of the Company. All sections 
contained herein have been subject to audit as required 
by section 308(3C) of the Corporations Act. Remuneration 
is referred to as compensation in this report. Details of 
KMP including remunerated executives of the Group are 
set out in the tables on pages 21 and 22. Unless otherwise 
indicated, the individuals were KMP for the entire 
financial year. There have been no changes to KMP after 
the reporting date and before the date of this report.  

Principles of compensation and strategy

The full Board assesses the appropriateness of the 
nature and amount of remuneration of NEDs and senior 
executives on a periodic basis by reference to relevant 
employment market conditions, with the overall objective 
of ensuring maximum stakeholder benefit from the 
retention of a high performing director and executive 
team and aligning the interests of the executives with 
those of the shareholders.

TALi Digital Limited’s remuneration strategy is designed 
to attract, motivate and retain employees and NEDs 
by identifying and rewarding high performers and 
recognising the contribution of each employee to the 
continued growth and success of the Group. To this end, 
key objectives of the Group’s reward framework are to 
ensure that remuneration practices are aligned to the 
Group’s business strategy, offer competitive remuneration 
benchmarked against the external market, provide strong 
linkage between individual and Group performance 
and rewards and align the interests of executives with 
shareholders. 

Where relevant, the remuneration framework 
incorporates at risk components through Short-
term Incentives (STI) and Long-term Incentives (LTI) 
arrangements tailored to the particular executive by 
reference to both financial and other metrics which 
generate value for shareholders. The Board also sets 
the aggregate fee pool for NEDs (which is subject 
to shareholder approval) and NED fee levels. In 
accordance with best practice corporate governance, 
the structure of NED and executive remuneration is 
separate and distinct.

The Board assumes full responsibility for compensation 
policies and packages applicable to directors and senior 
executives of the Group. The broad compensation policy 
is to ensure the compensation package appropriately 
reflects the person’s duties and responsibilities, and 
that compensation levels are competitive in attracting, 
retaining and motivating people who possess the 
requisite level of skill and experience. Employees may 
receive at-risk incentive payments remunerated as cash 
and/or securities (performance rights or options) based 
on the achievement of specific goals related to the 
performance of the individual and the Group as a whole 
as determined by the directors. Incentives are provided to 
senior executives and employees for the achievement of 
individual and strategic objectives with the broader view 
of creating value for shareholders.

Fixed compensation

Fixed compensation consists of a base salary package, 
which includes Fringe Benefits Tax calculated on 
any salary packaging arrangements and employer 
superannuation contributions. Fixed compensation levels 
for KMPs and senior members of staff are reviewed by 
the Board and comprising the Group’s KMP, through 
a process that considers the employee’s personal 
development, achievement of key performance objectives 
for the year, industry benchmarks wherever possible 
and CPI data. The Board’s policy is to ensure that fixed 
remuneration is market competitive having regard to 
industry peers and companies of similar financial size. 
Given the Group’s size it is not considered necessary 
to engage remuneration consultants for this purpose 
and accordingly the Group undertakes its own informal 
review, which it does on an ongoing basis.

Key Performance Indicators (KPIs) are individually tailored 
by the Board in advance for each employee each year, 
and reflect an assessment of how that employee can 
fulfill his or her particular responsibilities in a way that 
best contributes to Group performance and shareholder 
wealth in that year with close alignment to the role and 
responsibility within the organisation and in conjunction 
with the strategic objectives of the Group. 

TALi Digital Limited Annual Report 2021  |  17

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remuneration Report continued

FOR THE YEAR ENDED 30 JUNE 2021

Performance linked compensation 

All employees are potentially eligible to receive at-risk 
incentive payments and/or securities (shares or options) 
based on the achievement of specific goals related to: 

(i)  performance against individual key performance 

indicators; and/or

(ii)  the performance of the Group as a whole as 

determined by the Board based on a range of 
factors. 

These factors include traditional financial considerations 
such as operating performance, cash consumption and 
deals concluded and also industry specific factors. The 
purpose of these payments is to reward employees for their 
contribution to the Group. Employment contracts for staff 
other than the KMPs do not generally provide for at-risk or 
short-term incentive compensation arrangements having 
regard to the above factors although the Board always 
retains the right to agree or otherwise provide payments 
on a discretionary basis in special circumstances or where 
individual performance merits a payment being made. 

The Board is responsible for the determination of 
incentive compensation for employees and executives 
and for any decisions to award performance incentives. 
The Board at its sole discretion determines the total 
amount of performance-linked compensation payable 
as a percentage of the total annualised salaries for all 
employees employed as at the end of the financial year 
(with pro rata reductions to the annualised salary made for 
any employee not employed for the entire financial year).

The Directors have the discretion to recommend the offer 
of performance rights to acquire ordinary shares, options 
or the direct issue of shares to any member of staff in 
recognition of exemplary performance.

Such securities may be fully vested upon issue given that 
they are issued as a reward for past performance rather 
than as an LTI. Any issue of such securities proposed 
as incentive compensation requires approval by the 
Board and is subject to any limitations imposed by the 
Corporations Act and the ASX Listing Rules. As at the date 
of this report, no such securities have been issued.

At, or as soon as practicable after, the beginning of the 
financial year, individual and team performance for the 
previous year is assessed for every employee by their 
manager and new objectives set for the forthcoming year. 
These objectives include department and project specific 
objectives together with individual stretch objectives, 
challenging, realistic and personal development 
objectives tailored to the employee’s role within the 
organisation. Measurement, management support, 
target dates and training course requirements are all 
set. Progress against the objectives is reviewed during 
the year and percentage achievement concluded at the 
end of the year, whereupon the cycle recommences. The 
outputs of this process form the basis of the assessment of 
the individual’s personal incentive compensation.

The Board has discretion to reduce, cancel or clawback 
any unvested performance-based remuneration in the 
event of serious misconduct or a material misstatement 
in the Group’s financial statements. All Performance 
Rights are also subject to an overriding condition that 
the financial performance of the Group, in the absolute 
discretion of the Board, has been satisfactory.

18  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service contracts

Remuneration arrangements for executives are formalised in employment agreements. The following outlines the details 
of contracts with executives

Termination by 
Company (death, 
disablement, 
redundancy etc)

Termination for 
cause

Notice period

Payment in lieu of 
notice

Treatment of Short-
Term incentives

Treatment of Long-
Term Incentives

3 months (6 months 
for CEO)

3 months (6 months 
for CEO) 

Any STI payments are 
at Board discretion

At the discretion of the 
Board. 

None

None

Any STI payments are 
at Board discretion

Unvested awards 
forfeited. Vested and 
unexercised awards 
forfeited.

Resignation by 
employee

6 weeks (3 months for 
CEO)

None

Any STI payments are 
at Board discretion

Unvested awards 
forfeited. 

Performance linked compensation 

The Company Secretary is engaged by the Company under a consultancy agreement. The agreement provides a fixed 
monthly fee for “in scope” services with additional work charged at hourly rates. The consultancy agreement is a rolling 
contract and can be terminated by either party by giving two months’ notice in writing to the other party. 

Long Term Incentive (LTI)

From time to time Board approval may be sought for the issue of securities (performance rights or options) to staff 
and executives as a means of providing a medium to long term incentive for performance and loyalty. Any such 
performance rights are issued under the TALi Digital Performance Rights Plan.

An amount of $92,295 (2020: $8,705) has been recognised in the 2021 financial year by way of shared based payment 
expense. In order to give the incentive medium to long term impact, the performance rights have an approximate three-
year life and a vesting profile as shown later in this report. 

TALi Digital Limited Annual Report 2021  |  19

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remuneration Report continued

FOR THE YEAR ENDED 30 JUNE 2021

Director compensation

The Constitution and the ASX Listing Rules specify that the aggregate compensation of non-executive directors shall be 
determined from time to time by a general meeting. An amount not exceeding the amount approved by shareholders is 
then divided between the directors as agreed by the Board. An amount of $350,000 was approved at the Company’s 
inaugural Annual General Meeting held on 4 October 2005. The Board does not intend to seek any increase for the 
Non-Executive Director (NED) maximum aggregate fee pool at the 2021 AGM.

The board seeks to set NED fees at a level which provides the Group with the ability to attract and retain NEDs of the 
highest calibre, whilst incurring a cost which is acceptable to shareholders. 

The maximum aggregate fee pool and the fee structure is reviewed annually against fees paid to NEDs of comparable 
companies in similar industries.

Non-executive directors do not receive performance related compensation and the structure of non-executive director 
and senior management compensation is separate and distinct. Non-executive directors do not have contracts of 
employment but are required to evidence their understanding and compliance with the Board policies of TALi Digital 
Limited. These Board policies do not prescribe how compensation levels for non-executive directors are modified from 
year to year. Compensation levels are to be reviewed by the Board each year taking into account cost of living, changes 
to the scope of the roles of the directors, and any changes required to meet the principles of the overall Board policies.

Arrangements with key management personnel

Position

Annual salary (inclusive of superannuation)

Non-Executive Chair

Non-Executive Directors

$60,000

$35,000

NEDs may be reimbursed for expenses reasonably incurred in attending to the Group’s affairs. NEDs do not receive 
retirement benefits, nor do they participate in any incentive programs.

20  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ and Executive Officers’ compensation tables

Details of the nature and amount of each major element of the compensation of each director of the Group and each 
of the 2 named officers of the Group receiving the highest compensation for the period that the director or officer held 
that position during the current and prior financial years are disclosed in accordance with Accounting Standard AASB 
124 Related Party Disclosures and with the Corporations Act 2001 in the following tables.

Details of the Group’s policy in relation to the proportion of compensation that is performance related are provided 
earlier in this report. For the individuals named in the Directors’ and Executive Officers’ compensation tables, details of 
their service contracts are provided under the heading of “Service contracts” earlier in this report.

2021:

Base 
compensation 
(salary and fees) 
$

Bonuses / 
incentives 
$

Post 
Employment: 
Superannuation 
contributions 
$

Share-based 
payments: 
Shares and 
performance 
right’s issued 
$

Total 
compensation 
$

Directors

Non-executive

Ms S MacLeman

Mr J Harcourt

Dr D Brookes

Total compensation

Executive Directors 

54,788

35,000

31,963

121,751

-

-

-

-

Mr G Smith

250,000

93,750

371,751

93,750

5,205

-

3,037

8,242

23,750

31,992

-

-

20,391

59,993

35,000

55,391

20,391

150,384

70,500

438,000

90,891

588,384

TALi Digital Limited Annual Report 2021  |  21

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remuneration Report continued

FOR THE YEAR ENDED 30 JUNE 2021

2020:

Base 
compensation 
(salary and fees) 
$

Bonuses / 
incentives 
$

Post 
Employment: 
Superannuation 
contributions 
$

Share-based 
payments: 
Shares and 
performance 
right’s issued 
$

Total 
compensation 
$

Directors

Non-executive

Ms S MacLeman

Mr M Simari 2

Mr J Harcourt

Dr D Brookes 1

Total non-executive 

compensation

Executive Directors 

54,775

34,708

35,000

-

124,483

-

-

-

-

-

Mr G Smith 3

250,000

62,500

374,483

62,500

1   Appointed on 29 June 2020

2 Resigned 29 June 2020

5,204

-

-

-

5,204

25,729

30,933

-

-

-

-

-

-

-

59,979

34,708

35,000

-

129,687

338,229

467,916

3  Due to changes in the structure of the company from 1 July 2019, Glenn Smith was deemed to be the only employee categorised as key 

management personnel.

22  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Grants, modifications and exercise of options and rights over equity instruments granted as compensation

Number of options

Grant date

Expiry date

Exercise price

Grantee

6,800,000

3,400,000

3,400,000

08/10/2018

08/10/2018

24/11/2020

21/11/2022

21/11/2022

21/11/2025

22,500,000

24/11/2020

26/11/2020

$0.030

$0.030

$0.030

$0.030

Ms S MacLeman

Mr J Harcourt

Dr D Brookes

Mr G Smith

On 23 September 2020, 14,377,766 options previously issued to the CEO and Managing Director were cancelled.

During the year 22,500,000 (2020: 14,377,766) options to acquire ordinary shares were issued to the CEO & Managing 
Director approved by Shareholders at the Annual General Meeting (AGM) held on 24 November 2020.

Shares issued on exercise of options and performance rights

During the financial year the Company issued nil (2020: nil) ordinary shares upon the exercise of options or 
performance rights to Directors for total proceeds of nil (2020: nil). Since the end of the financial year up to the date of 
this report the Company has issued nil (2020: nil) shares upon exercise of options or performance rights to Directors for 
total proceeds of nil (2020: nil).

Alteration to option terms

There have been no alterations to option terms and conditions during or since the end of the financial year up to the 
date of this report.

Equity holdings and transactions 

The movements during the reporting period and prior reporting period in the number of ordinary shares in TALi Digital 
Limited (formerly Novita Healthcare Limited) held, directly or indirectly or beneficially, by each specified director and 
specified executive, including their personally-related entities are shown in the following tables. For persons who 
commenced or ceased as a Director during a period, figures reported are for the period of appointment only.

TALi Digital Limited Annual Report 2021  |  23

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remuneration Report continued

FOR THE YEAR ENDED 30 JUNE 2021

Number of shares held in TALi Digital Limited:

2021:

Holding of Ordinary 
Shares at 1 July 2020 
(or date of 
appointment)

Granted as 
compensation

Received 
on exercise 
of options/
performance 
shares

Net other 
change

Balance on 
Resignation

Holding of 
Ordinary 
Shares at 
30 June 
2021 

Number

Number

Number

Number

Number

Number

505,920

38,688,423

1,454,546

3,000,000

43,648,889

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

505,920

38,688,423

1,454,546

3,000,000

- 43,648,889

Directors

Ms S MacLeman

Mr J Harcourt

Mr G Smith

Dr D Brookes

Total

2020:

Holding of Ordinary 
Shares at 1 July 2019 
(or date of 
appointment)

Granted as 
compensation

Received 
on exercise 
of options/
performance 
shares

Net other 
change

Balance on 
Resignation

Holding of 
Ordinary 
Shares at 
30 June 
2020 

Number

Number

Number

Number

Number

Number

Directors

Ms S MacLeman

292,814

Mr J Harcourt

28,688,423

Mr M Simari 

Mr G Smith

Dr D Brookes

Total

3,000,000

1,000,000

-

32,981,237

-

-

-

-

-

-

-

-

-

-

-

-

-

213,106

10,000,000

-

-

505,920

38,688,423

1,363,637

(4,363,637)

-

454,546

3,000,000

-

-

1,454,546

3,000,000

15,031,289 (4,363,637) 43,648,889

24  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of options held in TALi Digital Limited:

2021:

Balance at 1 July 
2020 (or date of 
appointment)

Granted as 
compensation

Exercised / elapsed

Balance at 30 June 
2021

Number

Number

Number

Number

6,800,000

3,400,000

14,377,766

-

-

-

-

6,800,000

3,400,000

22,500,000

(14,377,766)

22,500,000

-

3,400,000

-

3,400,000

24,577,766

25,900,000

(14,377,766)

36,100,000

Balance at 1 July 
2019 (or date of 
appointment)

Granted as 
compensation

Exercised / elapsed

Balance at 30 June 
2020

Number

Number

Number

Number

6,800,000

3,400,000

3,400,000

14,377,766

-

-

-

-

-

-

14,377,766

(14,377,766)

6,800,000

3,400,000

3,400,000

14,377,766

27,977,766

14,377,766

(14,377,766)

27,977,766

Directors

Ms S MacLeman

Mr J Harcourt

Mr G Smith

Dr D Brookes

Total

2020:

Directors

Ms S MacLeman

Mr J Harcourt

Mr M Simari 1

Mr G Smith

Total

1 Mr M Simari resigned 29 June 2020.

Due to changes in the structure of the company from 1 July 2019, Glenn Smith was deemed to be the only employee 
classified as key management personnel.

TALi Digital Limited Annual Report 2021  |  25

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remuneration Report continued

FOR THE YEAR ENDED 30 JUNE 2021

Consequences of performance on shareholder wealth 

In considering the Group’s performance and how best to generate shareholder value, the Board has regard 
to a broad range of factors, some of which are financial and others of which relate to the technical and 
commercial progress on the Group’s projects and, where applicable, relationship building with health clinics and 
institutions and internal innovation etc. The Board has some but not absolute regard to the Group’s result and 
cash consumption for the year. It does not utilise earnings per share as a performance measure and does not 
contemplate consideration of any dividends in the short to medium term given that all efforts are currently being 
devoted to obtaining value for the Group’s assets and where possible building the business and partnerships to 
establish self-sustaining revenue streams and total shareholder value. The Group is of the view that any short term, 
adverse movements in the Company’s share price should not necessarily be taken into account in assessing the 
performance of KMP’s.

This report is made with a resolution of the directors.

Sue MacLeman 
Chair

30th of September 2021

26  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TALi Digital Limited Annual Report 2021  |  27
TALi Digital Limited Annual Report 2021  |  27

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collins Square, Tower 5 
727 Collins Street 
Melbourne VIC 3000 

Correspondence to: 
GPO Box 4736 
Melbourne VIC 3001 

T +61 3 8320 2222 
F +61 3 8329 2200 
E info.vic@au.gt.com 
W www.grantthornton.com.au  

Auditor’s Independence Declaration 

To the Directors of TALi Digital Limited 

In accordance with the requirements of section 307C of the Corporations Act 2001, as lead auditor for the audit of  
TALi Digital Limited for the year ended 30 June 2021, I declare that, to the best of my knowledge and belief, there have been: 

a 

b 

no contraventions of the auditor independence requirements of the Corporations Act 2001 in relation to the audit; and 

no contraventions of any applicable code of professional conduct in relation to the audit. 

Grant Thornton Audit Pty Ltd 
Chartered Accountants 

M A Cunningham 
Partner – Audit & Assurance 

Melbourne, 30 September 2021 

Grant Thornton Audit Pty Ltd ACN 130 913 594 
a subsidiary or related entity of Grant Thornton Australia Ltd ABN 41 127 556 389 

www.grantthornton.com.au 

‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients 
and/or refers to one or more member firms, as the context requires. Grant Thornton Australia Ltd is a member firm of Grant Thornton International 
Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are 
delivered by the member firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate one 
another and are not liable for one another’s acts or omissions. In the Australian context only, the use of the term ‘Grant Thornton’ may refer to 
Grant Thornton Australia Limited ABN 41 127 556 389 and its Australian subsidiaries and related entities. GTIL is not an Australian related entity to 
Grant Thornton Australia Limited. 

Liability limited by a scheme approved under Professional Standards Legislation. 

28 |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Statement of Profit or Loss  
and Other Comprehensive Income

FOR THE YEAR ENDED 30 JUNE 2021

Statement of profit or loss and other comprehensive income 
For the year ended 30 June 2021

Note

Revenue

Revenue from continuing operations

Other income

Total revenue and income

Expenses

Contract research and development expenses

Personnel expenses excluding share-based payment expense

Share based payment expense

Depreciation and amortisation expenses 

Occupancy expenses

Professional and consulting expenses

Travel and accommodation expenses

Insurance expenses

Corporate administration expenses

Intellectual property expenses

Advertising and promotion

Other expenses 

Total expenses

Operating loss

Net finance income / (expense)

Foreign exchange gains/(losses)

Loss before income tax expense

Income tax expense

Loss after income tax expense for the year attributable to the 
owners of TALi Digital Limited

Other Total comprehensive (loss)/income

Items that will not be reclassified subsequently to profit or loss

Net change in fair value of Investments

Total comprehensive (loss)/income for the year attributable 
to the owners of TALi Digital Limited

Basic earnings per share

Diluted earnings per share

4

5

21

6(a)

6(b)

7

8

9

9

2021 
$

34,238

514,667

548,905

(233,632)

(2,191,833)

(92,295)

(541,501)

(35,804)

(731,408)

(19,925)

(110,131)

(236,545)

(106,265)

(885,247)

(277,479)

2020 
$

47,229

574,715

621,944

36,427 

(1,841,093)

(8,705)

(548,913)

(52,780)

(631,063)

(129,472)

(85,103)

(86,468)

(128,042)

(342,132)

(186,268)

(5,462,065)

(4,003,612)

(4,913,160)

(3,381,668)

(9,311)

64,198 

(14,362)

(1,908)

(4,858,273)

(3,397,938)

-

-

(4,858,273)

(3,397,938)

-

(800,000)

(4,858,273)

(4,197,938)

Cents

(0.59)

(0.59)

Cents

(0.51)

(0.51)

The above consolidated statement of profit or loss and other comprehensive income should be read in conjunction 
with the accompanying notes.

TALi Digital Limited Annual Report 2021  |  29

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Statement of Financial Position

AS AT 30 JUNE 2021

Statement of financial position 
as at 30 June 2021

Current assets

Cash and cash equivalents

Trade and other receivables

Investments

Other assets

Total current assets

Non-current assets

Investments

Intangible assets

Property, plant and equipment 

Total non-current assets

Total assets

Current liabilities

Trade and other payables

Deferred income

Lease liabilities

Employee benefits

Total current liabilities

Non-current liabilities

Deferred income

Lease liabilities

Employee benefits

Total non-current liabilities

Total liabilities

Net assets

Equity

Issued capital

Reserves

Accumulated losses

Total equity

Note

2021 
$

2020 
$

10

11

12

13

12

14

15

16

17

18

19

17

18

19

2,726,518 

847,223 

1,688 

2,016,270 

5,591,699 

-  

4,126,199 

113,309 

4,239,508 

9,831,207

250,338 

145,674 

55,792 

159,344 

611,148 

3,945,408 

956,067 

1,418 

29,144 

4,932,037 

-  

3,322,432 

316,972 

3,639,404 

8,571,441

888,417 

261,642 

136,915 

125,820 

1,412,794 

1,936,746

1,424,274

-

27,266

1,964,012

2,575,160

7,256,047

55,312

12,505

1,492,091

2,904,885

5,666,556

20

208,157,446

202,113,795

502,351

98,238

(201,403,750)

(196,545,477)

7,256,047

5,666,556

The above consolidated statement of financial position should be read in conjunction with the accompanying notes.

30  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Statement of Changes in Equity

FOR THE YEAR ENDED 30 JUNE 2021

Issued capital 
$

Share based 
payments 
reserve  
$

Change in 
fair value 
reserve 
$

Accumulated 
losses 
$

Total 
equity 
$

202,113,795

1,098,238

(1,000,000)

(196,545,477)

5,666,556

For the year ended  
30 June 2021

Opening balance  
as at 1 July 2020

Loss after income tax expense 
for the year

Other Total comprehensive 
(loss)/income for the year, net 
of tax

Total comprehensive (loss)/
income for the year

-

-

-

-

-

-

-

-

Issue of ordinary shares

6,549,420

Transaction costs relating to 
issue of ordinary shares

(568,230)

Share-based payment 
transactions to employees

Share-based payment 
transactions to brokers and 
shareholders

Issue of ordinary shares from 
exercise of options

-

-

92,295

311,818

62,461

-

-

-

-

-

-

-

-

-

(4,858,273)

(4,858,273)

-

-

(4,858,273)

(4,858,273)

-

-

-

-

-

6,549,420

(568,230)

92,295

311,818

62,461

Balance at 30 June 2021

208,157,446

1,502,351

(1,000,000)

(201,403,750)

7,256,047

TALi Digital Limited Annual Report 2021  |  31

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Statement of Changes in Equity

FOR THE YEAR ENDED 30 JUNE 2020

Issued capital 
$

Share based 
payments 
reserve  
$

Change in 
fair value 
reserve 
$

Accumulated 
losses 
$

Total 
equity 
$

194,976,507

638,126

(200,000)

(193,147,539)

2,267,094

For the year ended  
30 June 2020

Balance  
as at 1 July 2019

Loss after income tax expense 
for the year

Other Total comprehensive 
(loss)/income for the year, net 
of tax

Total comprehensive (loss)/
income for the year

-

-

-

Issue of ordinary shares

8,200,000

Transaction costs relating to 
issue of ordinary shares

(1,062,712)

Share-based payment 
transactions to employees

Share-based payments  
to brokers

-

-

8,705 

451,407 

-

-

-

-

-

-

(3,397,938)

(3,397,938)

(800,000)

-

(800,000)

(800,000)

(3,397,938)

(4,197,938)

-

-

-

-

-

-

-

-

8,200,000

(1,062,712)

8,705 

451,407 

Balance at 30 June 2020

202,113,795

1,098,238

(1,000,000)

(196,545,477)

5,666,556 

32  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Statement of Cash Flows

FOR THE YEAR ENDED 30 JUNE 2021

For the year ended 30 June 2021

Note

2021 
$

2020 
$

Cash flows from operating activities

Receipts from customers from continuing operations

39,906 

53,854 

Payments to suppliers and employees

(6,997,809)

(3,785,688)

R&D tax incentive

Grants received

Interest received

Net cash used in operating activities

Cash flows from investing purchases

Payments for intangible assets

Payments for property, plant and equipment

694,848 

461,738 

3,271 

750,103 

232,960 

30,833 

(5,798,046)

(2,717,938)

(1,548,718)

(23,283)

(648,826)

(65,479)

Proceeds from disposal of property, plant and equipment

299 

-  

Net cash used in investing activities

Cash flows from financing activities

Proceeds from issue of shares

Share issue costs

Repayment of lease liabilities

Proceeds from borrowings

Repayment of borrowings

Net cash used in financing activities

Net (decrease)/increase in cash and cash equivalents

(1,571,702)

(714,305)

6,560,776 

8,200,001 

(256,412)

(137,073)

-  

-  

6,167,291

(1,202,457)

(611,302)

(122,514)

178,430 

(608,398)

7,036,217

3,603,974

Cash and cash equivalents at the beginning of the financial year

3,945,408 

341,434 

Effects of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at the end of the financial year

10

(16,433)

2,726,518

-  

3,945,408 

The above consolidated statement of cash flows should be read in conjunction with the accompanying notes.

TALi Digital Limited Annual Report 2021  |  33

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Financial Statements

FOR THE YEAR ENDED 30 JUNE 2021

1. Reporting entity

2. Basis of preparation

3. Significant accounting policies

4. Revenue from continuing operations

5. Other income

6. Profit before related income tax expense

7. Finance income and finance costs

8. Income tax expense

9. Earnings per share

10. Cash and cash equivalents

11. Trade and other receivables

12. Investments

13. Other assets

14. Intangible assets

15. Property, plant and equipment

16. Trade and other payables

17. Deferred income

18. Lease liabilities

19. Employee benefits

20. Issued capital

21. Share-based payments

22. Notes to the statement of cash flows

23. Financial instruments disclosure and financial risk management

24. Dividends

25. Dividend franking account

26. Auditors’ remuneration

27. Segmented reporting

28. Related party transactions

29. Group entities

30. Parent entity disclosure

31. Commitments

32. Contingent liabilities

33. Events after the reporting period

35

35

36

42

42

42

43

43

44

44

45

45

46

46

49

50

50

50

51

52

53

56

57

61

61

61

61

61

62

62

63

63

63

34  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

1. Reporting entity

TALi Digital Limited (the “Company”) is a company
domiciled in Australia. The consolidated financial
statements of the Company as at 2021 comprise
the Company and its subsidiary entities (together
referred to as the “Group” and individually as
“Group entities”). The Group primarily is involved in
research and development, for commercialisation,
of medical technology projects. The Company is a
public company listed on the ASX, incorporated and
domiciled in Australia, and with a registered office
and principal place of business located at Level
5, 19 William Street, Cremorne Vic 3121. Except as
disclosed elsewhere in this Report, there have been
no significant changes in the nature of these activities
during the year.

2. Basis of preparation

(a) Statement of compliance

The consolidated financial statements are 
general purpose financial statements which have 
been prepared in accord-ance with Australian 
Accounting Standards (AASBs) (including Australian 
Interpretations) adopted by the Australian Accounting 
Standards Board (AASB) and the Corporations 
Act 2001. The consolidated financial statements 
comply with the International Financial Reporting 
Standards (IFRSs) and interpretations adopted by the 
International Ac-counting Standards Board.

The Company is of a kind referred to in ASIC 
Corporations (Rounding in Financial/Directors’ 
Reports) Instrument 2016/191 issued by the Australian 
Securities and Investments Commission (ASIC), 
relating to the rounding off of amounts in the 
consolidated financial statements. Amounts in the 
consolidated financial statements have been rounded 
off in accordance with that legislative instrument to 
the nearest dollar, unless specifically stated to be 
otherwise.

(b) Going concern

The financial statements have been prepared on 
the going concern basis, which contemplates 
continuity of normal business activities and the 
realisation of assets and discharge of liabilities  
in the normal course of business.

As disclosed in the financial statements for the year 
ended 30 June 2021, the consolidated entity incurred 
a loss of $4,858,273 (2020: $3,397,938) and had 
negative operating cash flows of $5,798,046 (2020: 
$2,717,938). The consolidated entity’s main activity is 
developing and commercialising the TALi products 
and various service lines which will require further 
funding and investment.

Despite this financial position, in the Directors 
opinion there are reasonable grounds to believe 
the consolidated entity will be able to continue as a 
going concern, able to pay its debts as and when 
they fall due, after consideration of the following:

• The Group has cash reserves of $2,726,518; and

• The Group is forecasting increased revenue

growth from the increased sales of licenses for
the TALi products, which will deliver greater cash
inflows.

The Directors have prepared projected cash flow 
information for the twelve months from the date of 
approval of these financial statements taking into 
consideration the uncertainty of multiple significant 
business impacting events that could occur in the next 
twelve months.

In response to the uncertainty arising from this, the 
Directors have considered a plausible forecast range. 
The lowest of these forecast ranges indicates that 
the Group is expected to continue to operate, within 
available cash levels. Key to the forecasts are relevant 
assumptions regarding the business, business model, 
any legal or regulatory restrictions, in particular:

• Receipt of the Research and Development tax
incentive for FY21 and FY22 at similar levels to
prior years;

• Mitigating actions including the deferral of non-
critical and discretionary operating expenditure,
which the Directors and management monitor
monthly; and

• Critically assessing the performance of business
operations to determine the most adequate use
of cash.

The Directors remain focused on the Group’s liquidity  
and expect to manage business operations in the 
forecast period whilst maintaining adequate liquidity. 
Based on the forecasts, the Directors believe that it 
remains appropriate to prepare the financial statements 
on a going concern basis.

Judgement has been exercised in considering the 
impacts that the Coronavirus (COVID-19) pandemic 
has had, or may have, on the Group based on known 
information. Other than a delay in anticipated 
revenue due to a change in socio-economic 
conditions especially in India, there does not currently 
appear to be either any significant impact upon the 
financial statements or any significant uncertainties 
with respect to events or conditions which may impact 
the Group unfavourably as at the reporting date or 
subsequently as a result of the Coronavirus 
(COVID-19) pandemic.

TALi Digital Limited Annual Report 2021  |  35

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

2. Basis of preparation (continued)

(c) Use of estimates and judgements

The preparation of consolidated financial statements 
conforms with Australian Accounting Standards which 
requires management to make judgements, estimates 
and assumptions that affect the application of policies 
and reported amounts of assets and liabilities, income 
and expenses. Actual results may differ from these 
estimates.

The estimates and underlying assumptions are 
reviewed on an ongoing basis. Revisions to accounting 
estimates are recognised in the period in which the 
estimate is revised if the revision only affects that period 
or in the period of the revision and future periods if the 
revision affects both current and future periods.

The key estimates and judgments made in preparing 
the financial statements are:

• Assessing the carrying amount and estimated

useful life of identifiable intangible assets (refer
to note 14); and

• Assessing the carrying amount of investments

(refer to note 12).

3. Significant accounting policies

The principle accounting policies adopted in the
preparation of the financial statements are set out
below. These policies have been consistently applied
to all the years presented, unless otherwise stated.

New or amended Accounting Standards and
Interpretations adopted

The consolidated entity has adopted all of the new or
amended Accounting Standards and Interpretations
issued by the Australian Accounting Standards Boards
(‘AASB’) that are mandatory for the current reporting
period.

Any new or amended Accounting Standards or
Interpretations that are not mandatory have not yet
been adopted.

The following Accounting Standards and Interpretations
are most relevant to the consolidated entity:

(a) AASB 15 Revenue recognition

Sale of goods

The Group follows AASB15 which is based on the 
principle that revenue is recognised when control of a 
good or service transfers to a customer.

36  |  TALi Digital Limited Annual Report 2021

To determine whether to recognise revenue, the 
Group follows a 5-step process:

1. Identifying the contract with a customer

2. Identifying the performance obligations

3. Determining the transaction price

4.  Allocating the transaction price to the

performance obligations

5.  Recognising revenue when/as performance

obligation(s) are satisfied.

Revenue from sale of goods is for a one-off fixed fee. 
In accordance with the 5-step approach, revenues 
are generally recognised at the time of delivery of the 
goods to the customer. Invoices for goods or services 
transferred are generally due upon receipt of the goods.

Government grants

Conditional government grants are recognised 
initially as deferred income when there is a 
reasonable assurance that they will be received 
and that the Group will comply with the conditions 
associated with the grant. Grants that compensate 
the Group for expenses incurred are recognised in 
profit or loss on a systematic basis in the same periods 
in which the expenses are recognised.

An unconditional grant is recognised in profit or loss 
as other income when the grant becomes receivable.

(b) Financial Instruments

Investments and other financial assets are initially 
measured at fair value. Transaction costs are included 
as part of the initial measurement, except for financial 
assets at fair value through profit or loss. Such assets 
are subsequently measured at either amortised 
cost or fair value depending on their classification. 
Classification is determined based on both the 
business model within which such assets are held 
and the contractual cash flow characteristics of the 
financial asset unless, an accounting mismatch is 
being avoided.

Financial assets are derecognised when the 
rights to receive cash flows have expired or have 
been transferred and the consolidated entity has 
transferred substantially all the risks and rewards of 
ownership. When there is no reason-able expectation 
of recovering part or all of a financial asset, it’s 
carrying value is written off.

Financial assets at fair value through profit or loss

Financial assets not measured at amortised cost or 
at fair value through other comprehensive income 
are classified as financial assets at fair value through 
profit or loss. Typically, such financial assets will be 
either: (i) held for trading, where they are acquired 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
for the purpose of selling in the short-term with an 
intention of making a profit, or a derivative; or (ii) 
designated as such upon initial recognition where 
permitted. Fair value movements are recognised in 
profit or loss.

Financial assets at fair value through other 
comprehensive income

Financial assets at fair value through other 
comprehensive income include equity investments 
which the group intends to hold for the foreseeable 
future and has irrevocably elected to classify them as 
such upon initial recognition.

For financial assets measured at fair value through 
other comprehensive income, the loss is recognised 
within other comprehensive income. In all other cases, 
the loss allowance is recognised in profit and loss.

Cash and cash equivalents comprise cash balances 
and call or term deposits. Accounting for finance 
income and costs are discussed in (3c).

(c) Financial income and costs

Finance income comprises interest income on funds 
invested, dividend income, and changes in the 
fair value of financial assets at fair value through 
profit or loss, gains on hedging instruments that 
are recognised in profit or loss and reclassifications 
of amounts previously recognised in other 
comprehensive income. Interest income is recognised 
as it accrues in profit or loss, using the effective 
interest method.

Finance costs comprise interest expense on 
borrowings, changes in the fair value of financial 
assets at fair value through profit or loss, impairment 
losses recognised on financial assets, and losses on 
hedging instruments that are recognised in profit 
or loss and reclassifications of amounts previously 
recognised in other comprehensive income.

(d) Goods and services tax

Revenue, expenses and assets are recognised net of 
the amount of Goods and Services Tax (GST), except 
where the amount of GST incurred is not recoverable 
from the taxation authority. In these circumstances, the 
GST is recognised as part of the cost of acquisition of 
the asset or as part of the expense.

Receivables and payables are stated with the amount 
of GST excluded. The net amount of GST recoverable 
from, or payable to, the Australian Taxation Office 
(ATO) is included as a current asset or liability in the 
balance sheet.

Cash flows are included in the statement of cash 
flows on a gross basis. The GST components of cash 
flows arising from investing and financing activities 
which are recoverable from, or payable to, the ATO 
are classified as operating cash flows.

(e) Foreign currency

Transactions in foreign currencies are translated 
at the foreign exchange rate ruling at the date of 
the transaction. Monetary assets and liabilities 
denominated in foreign currencies at the reporting 
date are translated to Australian dollars at the 
foreign exchange rate at that date. Foreign exchange 
differences arising on translation are recognised in 
the income statement.

Non-monetary assets and liabilities that are 
measured in terms of historical cost in a foreign 
currency are retranslated to Australian dollars 
using the foreign exchange rate at the date of the 
transaction. Non-monetary assets and liabilities 
denominated in foreign currencies that are measured 
at fair value are retranslated to Australian dollars  
at the ex-change rate at the date that the fair value  
was determined.

(f) Income tax

Income tax expense comprises current and deferred 
tax. Income tax expense is recognised in profit or loss 
except to the extent that it relates to items recognised 
directly in equity, in which case it is recognised in equity.

Current tax is the expected tax payable or receivable 
on the taxable income or loss for the year, using 
tax rates enacted or substantively enacted at the 
reporting date, and any adjustment to tax payable in 
respect of previous years.

Deferred tax is recognised using the balance sheet 
liability method, providing for temporary differences 
between the carrying amounts of assets and liabilities 
for financial reporting purposes and the amounts 
used for taxation purposes. Deferred tax is measured 
at the tax rates that are expected to be applied to 
the temporary differences when they re-verse based 
on the laws that have been enacted or substantively 
enacted by the reporting date.

A deferred tax asset is recognised only to the extent 
that it is probable that future taxable profits will be 
available against which the temporary difference  
can be utilised. Deferred tax assets are reviewed at 
each reporting date and reduced to the extent that it 
is no longer probable that the related tax benefit will 
be realised.

TALi Digital Limited Annual Report 2021  |  37

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

(g) Property, plant and equipment

(i) Cash and cash equivalents

Cash and cash equivalents comprise cash balances 
and short-term deposits with an original maturity of 
three months or less.

(j) Impairment

A financial asset is considered to be impaired if 
objective evidence indicates that one or more events 
have had a negative effect on the estimated future 
cash flows of that asset.

The carrying amounts of the Group’s assets are 
reviewed at each balance date to determine whether 
there is any indication of impairment. If any such 
indication exists, the recoverable amount of the asset 
is estimated.

An impairment loss in respect of an asset measured 
at amortised cost is calculated as the difference 
between the carrying amount and the present value 
of the estimated future cash flows discounted at the 
effective original interest rate.

Individually significant financial assets are tested for 
impairment on an individual basis. The remaining 
financial assets are assessed collectively in groups 
that share similar credit risk characteristics.

All impairment losses are recognised in profit or loss. 
Aside from impairment of goodwill, an impairment 
loss is reversed if the reversal can be related 
objectively to an event occurring after the impairment 
loss was recognised. For financial assets measured at 
amortised cost, the reversal is recognised in profit or loss.

The carrying amounts for non-financial assets are 
reviewed each reporting date to determine whether 
there is any indication of impairment. If any such 
indication exists, then the asset’s recoverable amount 
is estimated and an impairment loss recognised 
in profit or loss if the carrying amount of an asset 
exceeds its recoverable amount. The recover-able 
amount of an asset is determined as the greater of its 
value in use and its fair value less costs to sell. Value 
in use is assessed using discounted cash flow analysis. 
When determining fair value less costs to sell, TALi 
Digital takes into account information from recent 
market transactions and other available market-
based information.

(i) Owned assets

The Group holds no property. Items of plant and 
equipment are measured at cost less accumulated 
depreciation and impairment losses. Cost includes 
expenditures that are directly attributable to the 
acquisition of the asset. The costs of day to day servicing 
of plant and equipment are recognised in profit or 
loss as incurred. The cost of replacing part of an item 
of plant and equipment is recognised in the carrying 
amount of the asset if it is probable that the future 
economic benefits embodied within the part will flow  
to the Group and its costs can be measured reliably.

(ii) Depreciation

Depreciation is recognised in profit or loss on a 
straight-line basis over the estimated useful lives of 
each part of an item of plant and equipment.  
The estimated useful lives in the current and 
comparative periods are as follows:

•  Plant and equipment

2.5 – 10 years

•  Leasehold improvements

•  Right-of-use asset

3 years

3 years 

Depreciation methods, useful lives and residual 
values are reassessed annually at the reporting date.

(h) Intangible assets

Intangible assets acquired by the Group which 
satisfy the asset recognition criteria set out in 
AASB 138 Intangible Assets, are measured at cost 
less accumulated amortisation and accumulated 
impairment losses. Intangible assets which are 
considered to have a finite life are amortised over 
their estimated useful life. In respect of acquired 
licences / marketing rights, amortisation commences 
upon the asset becoming available for use, based 
on commercialisation of the licensed or marketed 
product. The estimated useful life of acquired 
intellectual property is 5-20 years (2020: 5-20 years).

Research and development

Research costs are expensed in the period in which 
they are incurred, Development costs are capitalised 
when it is probable that the project will be a success 
considering its commercial and technical feasibility; 
the consolidated entity is able to use or sell the asset; 
the consolidated entity has sufficient resources; and 
intent to complete the development and its costs can 
be measured realisably. Capitalised development 
costs are amortised on a straight-line basis over the 
period of their expected benefit being their finite life. 
Management assessed the finite life at 1 April 2021 
to be 14.5 years (previously 7 years) in line with the 
Group’s major patent expiry dates. 

38  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.  Significant accounting policies (continued)

(i) Provisions

(k) Employee benefits

(i) Long-term service benefits

The Group’s net obligation in respect of long-term 
employee benefits is the amount of future benefit that 
employees have earned in return for their service in 
the current and prior periods plus related on-costs. 
That benefit is discounted to determine its present 
value. The discount rate is the yield at the reporting 
date on corporate bonds that have maturity dates 
approximating the terms of the Group’s obligations.

(ii) Share-based payment transactions

The Group provides benefits to its employees in the 
form of share-based payments, whereby services 
are rendered in exchange for shares or rights over 
shares (equity-settled transaction). There is currently 
a Performance Rights Plan in place as part of the LTI, 
for the issue of share based payments to staff and 
KMP as a reward for performance and loyalty. LTI 
awards to executives are made under the executive 
Performance Rights plan and are delivered in the 
form of performance rights or zero exercise price 
options. The performance rights will vest over a 
period of  three years subject to meeting performance 
measures. The cost of the equity-settled transaction is 
recognised, together with a corresponding increase 
in equity, over the period in which the performance 
and/or service conditions are fulfilled (vesting 
period), ending on the date the relevant employees 
benefit become fully entitled to the award (the vesting 
date. The fair value of the performance rights is based 
on the Monte Carlo pricing model to test the likelihood 
of attaining the performance hurdles.

(iii)  Wages, salaries, annual leave and at-risk 

performance incentives

Liabilities for employee benefits for wages, salaries, 
annual leave and performance incentives represent 
present obligations resulting from employees’ services 
provided up to reporting date and are calculated 
at undiscounted amounts based on compensation 
wage and salary rates that the Group expects to 
pay as at reporting date including related on-costs, 
such as workers’ compensation insurance and payroll 
tax. Government stimulus payments such as PAYGW 
cash booster and JobKeeper are recorded as a 
reimbursement of expenditure.

(iv) Superannuation

Obligations for contributions to defined contribution 
superannuation funds are recognised as an expense 
in profit or loss when they are due. The Group has no 
defined benefit pension fund obligations.

A provision is recognised if, as a result of a past 
event, the Group has a present legal or constructive 
obligation that can be measured reliably, and it is 
probable that an outflow of economic benefits will 
be required to settle the obligation. Provisions are 
determined by discounting the expected future cash 
flows at a pre-tax rate that reflects current market 
assessments of the time value of money and, when 
appropriate, the risks specific to the liability.

Lease make good provision

A provision has been made for the present value 
of anticipated costs for future restoration of leased 
premises. The provision includes future cost estimates 
associated with closure of the premises. The 
calculation of this provision re-quires assumptions 
such as application of closure dates and cost estimates.

The provision recognised for each site is periodically 
reviews and updated based on the facts and 
circumstances available at the time.

Changes to the estimated future costs for sites are 
recognised in the statement of financial position by 
adjusting the asset and the provision. Reductions in 
the provision that exceed the carrying amount of the 
asset will be recognised in profit or loss.

(m) Right-of-use asset

At inception of a contract, the Group assesses 
whether a contract is, or contains, a lease. A contract 
is, or contains, a lease if the contract conveys the right 
to control the use of an identified asset for a period of 
time in exchange for consideration. To assess whether 
a contract conveys the right to control the use of an 
identified asset, the Group assesses whether:

•   The contract involves the use of an identified 
asset — this may be specified explicitly or 
implicitly and should be physically distinct asset. 
If the supplier has a substantiate substitution 
right, then the asset is not identified;

•   The Group has the right to obtain substantially 

all of the economic benefits from use of the asset 
throughout the period of use; and

TALi Digital Limited Annual Report 2021  |  39

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

Lease payments included in the measurement of the 
lease liability comprise:

•  Fixed payments, including in-substance fixed

payments;

• Variable lease payments that depend on an

index or a rate, initially measured using the index
or rate as at the commencement date;

• Amounts expected to be payable under a

residual value guarantee; and

• The exercise price under a purchase option

that the Group is reasonably certain to exercise,
lease payments in an optional renewal period
if the Group is reasonably certain to exercise
an extension option, and penalties for early
termination of a lease unless the Group is
reasonably certain not to terminate early.

The lease liability is measure at amortised coast using 
the effective interest method. It is remeasured when 
there is a change in future lease payments arising 
for a change in an index or rate, if there is a change 
in the Group’s estimate of the amount expected to 
be payable under a residual value guarantee or if 
the Group changes its assessment of whether it will 
exercise a purchase, extension or termination option.

When the lease liability is remeasured in this way,  
a corresponding adjustment is made to the carrying 
amount of the right-of-use asset or is recorded in 
profit or lost if the carrying amount of the right-of-use 
asset has been reduced to zero.

Short-term leases and leases of low-value assets

The Group has elected not to recognise right-of-use 
assets and lease liabilities for short-term leases that 
have a lease term of 12 months or less and leases of 
low-value assets, including IT equipment. The Group 
recognises the lease payments as associated with 
these leases as an expense on a straight-line basis 
over the lease term.

Payments made under short term operating leases 
are recognised in profit or loss on a straight-line basis 
over the term of the lease.

3. Significant accounting policies (continued)

(m) Right-of-use asset

• The Group has the right to direct the use of the
asset. The Group has the right when it has the
decision-making rights that are most relevant to
decision-making rights that are most relevant to
changing how and for what purpose the asset is
used. In rare cases where all the decisions about
how and for what purpose the asset is used are
predetermined, the Group has the right to direct
the use of the asset if either:

o The Group has the right to operate the

asset; or

o The Group designed the asset in a way that
predetermines how and for what purpose it
will be used.

At inception or on reassessment of a contract that 
contains a lease component, the Group allocates the 
consideration in the contract that contains a lease 
component, the Group allocates the consideration in 
the contract to each lease component on the basis of 
their relative stand-alone prices.

The Group recognises a right-of-use asset and a 
lease liability at the lease commencement date. The 
right-of-use as-set is initially measured at cost, which 
comprises the initial amount of the lease liability 
adjusted for any lease payments made at or before 
the commencement date, plus any initial direct 
costs incurred and an estimate of costs to dismantle 
and remove the underlying asset or to restore the 
underlying asset or the site on which it is located, less 
any lease incentives received.

The right-of-use asset is subsequently depreciated 
using the straight-line method from the 
commencement date to the earlier of the end of the 
useful life of the right-of-use asset or the end of the 
lease term. The Estimate useful lived of right-of-use 
assets are determined on the same basis as those of 
property and equipment. In addition, the right-of-use 
asset is periodically reduced by impairment losses, if 
any, and adjusted for certain re-measurements of the 
lease liability.

The lease liability is initially measured at the present 
value of the lease payments that are not paid at 
the commencement date, discounted using the 
interest rate implicit in the lease or, if that rate cannot 
be readily determined, the Group’s incremental 
borrowing rate. Generally, the Group uses its 
incremental borrowing rate as the discount rate.

40  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Significant accounting policies (continued)

(n) Research and development

Research expenditure undertaken with the prospect 
of gaining new scientific or technical knowledge 
or understanding is expensed in profit or loss as 
incurred. Development expenditure is capitalised 
only if development costs can be measured reliably, 
the product is technically and commercially feasible, 
future economic benefits are probable, and 
completion of development is intended.

(o) Segment reporting

A segment is a distinguishable component of a 
Group engaged in providing products or services 
within a particular business sector or geographical 
environment. The Group determines and presents 
operating segments based on information that 
internally is provided to and used by the Managing 
Director, who is the Group’s chief operating decision 
maker. From 1 July 2020 the Group deems to only 
operate within one business segment.

(p) Earnings per share

The Group presents basic and diluted earnings 
per share for its ordinary shares. Basic earnings per 
share (EPS) is calculated by dividing the profit or loss 
attributable to ordinary shareholders of the Company 
by the weighted average number of ordinary shares 
outstanding for the period. Diluted EPS is calculated 
by adjusting the profit or loss attributable to ordinary 
shareholders and the weighted average number 
of ordinary shares outstanding for the effects of all 
dilutive potential ordinary shares, including share 
options granted to employees and to third parties.

(q) Share capital

Incremental costs directly attributable to the issue of 
ordinary shares and share options are recognised as a 
deduction from equity, net of any associated tax benefit.

(r) Fair value reserve

The fair value reserve comprises the cumulative 
net change in the fair value of financial assets with 
changes in their fair value recognised in the Statement 
of Profit or Loss and Other Comprehensive Income.

(s) New standards and interpretations not yet
adopted

A number of new standards, amendments to 
standards and interpretations effective for annual 
periods beginning on or after 1 July 2021 have not 
been applied in preparing these consolidated 
financial statements. None of these is expected to 
have a significant effect on the consolidated financial 
statements of the Group.

(t) Non-current assets or disposal groups classified
as held for sale

Non-current assets and assets of disposal groups 
are classified as held for sale if their carrying amount 
will be recovered principally through a sale transaction 
rather than through continued use. They are measured 
at the lower of their carrying amount and fair value less 
costs of disposal. For non-current assets or assets of 
disposal groups to be classified as held for sale, they 
must be available for immediate sale in their present 
condition and their sale must be highly probably.

An impairment loss is recognised for any initial or 
subsequent write down of the non-current assets 
and assets of disposals groups to fair value less costs 
of disposal. A gain is recognised for an subsequent 
increases in fair value less costs of disposal of a  
non-current assets and assets of disposal groups, 
but not in excess of any cumulative impairment loss 
previously recognised.

Non-current assets are not depreciated or amortised 
while they are classified as held for sale. Interest and 
other expenses attributable to the liabilities of assets 
held for sale continue to be recognised.

TALi Digital Limited Annual Report 2021  |  41

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

4. Revenue from continuing operations

Sale of licences

5. Other income

Grant income

Other income

R&D tax incentive 

6. Profit before related income tax expense

a)  Profit before related income tax expense has been arrived at after

charging the following items:

Depreciation of plant and equipment

Amortisation of intangible assets

Amounts recognised in provisions for employee entitlements

Superannuation payments to defined contribution plans

b) Other expenses:

Workplace administration

Asset management

Other expenses

     Total other expenses 

2021 
$

34,238

2021 
$

125,204

297

389,166

514,667

2020 
$

47,229

2020 
$

97,215

68

477,432

574,715

2021 
$

2020 
$

224,550

316,951

172,607

169,596

271,608

3,371

2,500

277,479

218,618

330,295

139,195

173,705

181,622

1,646

3,000

186,268

42  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Finance income and finance costs

Recognised in profit or loss

Interest income on cash and cash equivalents

Finance income

Net change in fair value of financial assets at fair value through profit or loss:

Unwinding on lease liability

Interest charge on loan

Finance costs

Net finance income/(costs) recognised in profit or loss

8. Income tax expense

2021 
$

2,844

2,844

(7,050)

(5,105)

(12,155)

(9,311)

2020 
$

29,566

29,566

(15,097)

(28,831)

(44,738)

(15,172)

2021 
$

2020 
$

Numerical reconciliation between tax expense and pre-tax net loss:

Loss before tax – continuing operations

(4,858,273)

(3,397,938)

Current tax expense (benefit) - current year

Deferred tax expense - continuing operations

Aggregate income tax expense

Numerical reconciliation between tax expense and pre-tax net loss:

Loss become income tax expense

Tax at the statutory tax rate of 26% (2020: 27.5%)

Change in unrecognised temporary differences

Add: Non-deductible expenses

Add: Use of tax losses not recognised

Add: Research and development allowance

Less: Items deductible for tax purposes

Less: Items not assessable for tax purposes

Income tax expense

-

-

-

-

-

-

(4,858,273)

(3,397,938)

(1,263,151)

(934,433)

102,402

24,824

1,197,087

167,390

(105,864)

(122,688)

-

85,923

4,192

853,506

252,942

(103,336)

(158,794)

-

The deductible temporary differences and any tax losses do not expire under current tax legislation. Deferred tax assets 
have not been recognised in respect of these items because it is not probable that future taxable profit will be available 
from which the Group can utilise the benefits. There was no deferred tax recognised directly in equity. As at 30 June 
2021 the Group has revenue losses of approximately $159 million (2020: $154 million).

TALi Digital Limited Annual Report 2021  |  43

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

9. Earnings per share

2021 
$

2020 
$

Loss after income tax attributable to the owners of TALi Digital Limited

(4,858,273)

(3,397,938)

Weighted average number of ordinary shares

Weighted average number of ordinary shares used in calculating basic 
earnings per share

Number

Number

820,820,227

670,288,091

Weighted average number of ordinary shares used in calculating diluted 
earnings per share

820,820,227

670,288,091

Basic earnings per share (cents per share)

Diluted earnings per share (cents per share)

(0.59)

(0.59)

(0.51)

(0.51)

10.  Cash and cash equivalents

Current assets

Cash at bank

Cash on deposit

Total current cash and cash equivalents

Financing arrangements

2021 
$

2020 
$

1,776,338

148,058

950,180

3,797,350

2,726,518

3,945,408

A security bond of $100,000 was provided on a Bank Guarantee on the Group’s Cremorne premises. Interest on 
cash at bank is credited at prevailing market rates. The weighted average interest rate at reporting date was 
0.003% (2020: 0.46%).

44  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11. Trade and other receivables

Current assets

Trade and other receivables

R&D tax incentive and other tax receivables

Total current trade and other receivables

Allowance for expected credit losses

2021 
$

51,349

795,874 

847,223

2020 
$

214,719 

741,348 

956,067

The Group has recognised a loss of nil (2020: nil) in profit and loss in respect of the expected credit losses for the 
year ended 30 June 2021.

12. Investments

Current

2021 
$

2020 
$

Financial assets classified at fair value through the profit & loss

1,688

1,418

Non-current assets

Investments in equity instruments

Total

Reconciliation

Reconciliation of the fair values at the beginning and end of the 
current and previous financial year are set out below:

Opening fair value

Revaluation increments

Change in fair value recognised in other comprehensive income

Closing fair value

-

-

-

-

1,688

1,688

1,418

270

-

1,688

801,350

68

(800,000)

1,418

Investments in equity instruments are categorised as Level 1 within the fair value hierarchy and are valued using 
market observable rates, being quoted ASX stock prices. 

On 18 October 2018 Newly Pty Ltd, a fully owned subsidiary of Novita Healthcare, sold its entire business as a going 
concern. In consideration for the sale the consolidated entity received 600 fully paid shares (10%) in Healthcarelink 
Group Pty Ltd, plus the right to earn out shares. As part of the sale agreement 400 fully paid ordinary shares in the 
company were purchased at an issue price of $1,000 per share. 

During 2020, the Healthcarelink Group were unsuccessful in raising additional capital. Without the required 
injection of capital, the business was deemed to no longer be operating as a going concern. Therefore, under level 
3 of the fair value hierarchy, the investment was indirectly determined by the Board to have a fair value of $ nil. As a 
result, as at 30 June 2020, the asset was written off.

TALi Digital Limited Annual Report 2021  |  45

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

13. Other assets

Current assets

Prepayments

2021 
$

2020 
$

2,016,270

29,144

On 6 January 2021 $2,586,299 prepaid advertising credits were purchased from the Times Group India. As at 30 
June 2021 the Group has $1,973,180 in credits remaining which will be utilised as the Group executes it’s Indian 
advertising and marketing plan. The credits have an expiry of June 2022.

14. Intangible assets

Non-current assets

Development - at cost

Less: Accumulated amortisation

Intellectual property - at cost

Less: Accumulated amortisation

Acquired licences - at cost

Less: Accumulated amortisation

2021 
$

2020 
$

4,007,982 

2,887,266

(523,723)

3,484,259

1,149,074

(742,890)

406,184 

375,000

(139,244)

235,756 

(376,493)

2,510,773

1,149,074

(630,447)

518,627 

375,000

(81,968)

293,032

Total

4,126,199 

3,322,432 

46  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14. Intangible assets (continued)

Reconciliations of the written down values at the beginning and end of the current and previous financial year are 
set out below:

2021

Gross carrying amount

Carrying amount at beginning of 
period 

Acquired licenses 
$

Acquired 
intellectual 
property 
$

Internally 
generated 
 assets 
$

Total 
$

375,000

1,149,074

2,887,266

4,411,340

Addition, internally developed

-

-

1,120,716

1,120,716

Balance at 30 June 2021

375,000

1,149,074

4,007,982

5,532,056

Amortisation and impairment

Carrying amount at beginning of 
period 

Amortisation

Impairment losses

(81,968)

(630,447)

(376,493)

(1,088,908)

(57,276)

(112,443)

(147,230)

(316,949)

-

-

-

-

Balance at 30 June 2021

(139,244)

(742,890)

(523,723)

(1,405,857)

Carrying amount at 30 June 2021

235,756

406,184

3,484,259

4,126,199

TALi Digital Limited Annual Report 2021  |  47

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

14. Intangible assets (continued)

2020

Gross carrying amount

Acquired licenses 
$

Acquired 
intellectual 
property 
$

Internally 
developed assets 
$

Total 
$

Carrying amount at 1 July 2019

375,000

721,074

2,238,438 

3,334,512 

Addition, internally developed

Acquisition of intellectual property

-

-

-

648,828 

428,000

-

648,828 

428,000 

Balance at 30 June 2020

375,000

1,149,074 

2,887,266 

4,411,340 

Amortisation and impairment

Carrying amount at 1 July 2019

Amortisation

Impairment losses

Balance at 30 June 2020

Carrying amount at 30 June 2020

(63,218)

(18,750)

-

(81,968)

293,032

(486,232)

(144,215)

-

(209,163)

(167,330)

-

(758,613)

(330,295)

-

(630,447)

(376,493)

(1,088,908)

518,627

2,510,773

3,322,432

(i) Licences and intellectual property

On the acquisition of TALi Health Pty Ltd announced on February 15th 2016, TALi Digital recognised intellectual 
property (including licenses) at a fair value of $1,096,074. In June 2020 patents and other intellectual property were 
acquired in relation to TALi products at a fair value of $428,000. Intangibles are initially recognised at cost and 
amortised on a straight-line basis over the period of expected benefit, less any adjustments for impairment losses. 
The estimated useful life and amortisation method are reviewed at the end of each annual reporting period.

(ii) Internally developed assets

Internally developed assets include the applied development activities conducted on the TALi Technology in respect 
of the development stage of the TALi TRAIN and TALi DETECT projects. On 1 April 2021, the estimated useful life of 
the internally developed assets was reassessed based on a number of factors and which ultimately align the useful 
life of the assets to the expiry of the assets main issued patent. The estimated useful life was reassessed to be 14.5 
years (previously 7 years). The date of reassessment occurred on 1 April 2021 in line with the assets roll out to the 
Indian market. Both TALi TRAIN and TALi DETECT assets were assessed as available and ready for use for customers 
from the date of reassessment and have been amortised accordingly. 

An assessment was made by management to determine whether any indicators of impairment exist. Indicators 
assessed included but were not limited to; the Group’s market capitalisation, technology obsolescence, changes in 
laws and regulations and COVID-19. No indicators of impairment were identified. Management also considered the 
carrying value intangible assets not yet in use and determined the recoverable amount is greater than the carrying 
value of these assets.

48  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15. Property, plant and equipment

Non-current assets

Leasehold improvements - at cost

Less: accumulated depreciation

Property, plant and equipment – at cost

Less: accumulated depreciation

Right-of-use asset

Less: accumulated depreciation

Closing written down value

2021 
$

156,848

(130,994)

25,854

216,588 

(162,475)

54,113 

400,104 

2020 
$

162,543

(79,246)

83,297

191,982 

(125,017)

66,965 

400,104

(366,762)

(233,394)

33,342 

113,309 

166,710 

316,972 

Reconciliations

Reconciliations of the written down values at the beginning and end of the current and previous financial year 
are set out below:

Balance as at 1 July 2019

Additions

Disposals

Reclassifications

Depreciation expense

Leasehold 
improvements 
$

Plant and 
equipment 
$

Right-of-use 
asset 
$

Total 
$

108,549

28,549

(1,807)

-

59,337

40,884

-

-

311,192

479,078

-

- 

(11,114)

69,433

(1,807)

(11,114)

(51,994)

(33,256)

(133,368)

(218,618)

Balance at 30 June 2020

83,297

66,965

166,710

316,972

Additions

Disposals

Reclassifications

Depreciation expense

-

-

(5,694)

21,145

(258)

5,694

-

- 

-

21,145

(258)

-

(51,749)

(39,433)

(133,368)

(224,550)

Balance as at 30 June 2021

25,854

54,113

33,342

113,309

TALi Digital Limited Annual Report 2021  |  49

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

16. Trade and other payables 

Current liabilities

Trade payables

Accruals and other payables

2021 
$

100,010 

150,328 

250,338 

2020 
$

828,938 

59,479 

888,417 

The Group’s exposure to currency and liquidity risk related to trade creditors and accruals is disclosed in Note 23.

17. Deferred income

Current liabilities

2021 
$

2020 
$

Deferred income - R&D Incentive & Grant Income

145,674 

261,642 

Non-current liabilities

Deferred income - R&D Incentive & Grant Income

1,936,746 

1,424,274 

Reconciliation

Reconciliation of the written down values at the beginning and end of 
the current and previous financial year are set out below:

Opening balance

Current year additions

Release of deferred revenues to the Profit and Loss

Closing balance

1,685,916

487,512

(91,008)

2,082,420

1,398,322

371,463

(83,869)

1,685,916

Due to the deferral of the TALi products Development Cost Intangible Assets amortisation as indicated in note 14,  
the related deferred R&D grant income and CRC-P grant revenue has been bought into account over the 
amortisation period. This has resulted in a total  of $389,166 (2020: $477,432) of R&D grant income and $10,205 
(2020: $97,215) in CRC-P grant income being recognised in the Profit or Loss for the year ended 30 June 2021. 
$1,498,894 (2020: $1,092,186) of R&D grant income relating to future periods and $583,526 (2020: $593,730) in 
Grant revenue has been classified as Deferred Income.

18. Lease liabilities

Current liabilities

Lease liability

Non-current liabilities

Lease liability

2021 
$

2020 
$

55,792 

136,915 

-

55,792

55,312

192,227

The lease liability relates to the office lease held by the Group. The lease has been accounted for in accordance 
with AASB 16. 

Refer to note 23 for further information on financial instruments disclosure and financial risk management.

50  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19. Employee benefits

Current liabilities

Employee benefits provision

Non-current liabilities

Employee benefits provision

2021 
$

2020 
$

159,344

125,820

27,266

186,610

12,505

138,325

At-risk incentive performance payments

Compensation for all employees other than non-executive directors includes an at-risk performance component. 
Provision has been made at reporting date for the amount payable in respect of performance for the financial year 
as measured against agreed criteria set on an employee by employee basis.

A reconciliation of movement for the year for all employee provisions is provided in the following table.

2020

Balance at 1 July 2019

Provision utilised

Charges raised

Balance at 30 June 2020 

2021

Balance at 1 July 2020

Provision utilised

Charges raised

Balance at 30 June 2021 

Annual leave  
$

Long service leave 
$

111,594

(110,908)

125,134

125,820

54,538

(33,291)

(8,742)

12,505

Total 
$

166,132

(144,199)

116,392

138,325

Annual leave  
$

Long service leave 
$

Total 
$

125,820

(124,322)

157,846

159,344

12,505

138,325

-

(124,322)

14,761

27,266

172,607

186,610

TALi Digital Limited Annual Report 2021  |  51

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

20. Issued capital

Terms and conditions of ordinary shares

Holders of ordinary shares are entitled to one vote per share at shareholders’ meetings and to receive any dividends 
as may be declared. In the event of winding up of the Company, ordinary shareholders rank after all creditors and 
are fully entitled to any proceeds of liquidation. Ordinary shares have no par value.

Shares

2021

2020

Number

$

Number

$

Ordinary shares, fully paid 

931,905,789

208,157,446 

749,305,218

202,113,795 

Movements in issued capital during 
the year were as follows:

Balance at the beginning of the 
financial year

749,305,218

202,113,795

449,305,165

194,976,507

Issue of shares through placement

180,518,542

6,549,420

300,000,053

8,200,000

Issue of shares on exercise of options

2,082,029

62,461

-

(568,230)

-

-

-

(1,062,712)

Transaction costs relating to rights issue 
and placements(1)

Issued capital at the end of the 
financial year

931,905,789

208,157,446

749,305,218

202,113,795

1  Directly attributable costs incurred in raising capital are presented as a reduction in equity. Costs that are a 
reduction of equity include $311,818 share based payment in relation to 15,000,000 options were provisionally 
issued to the Broker of the placement on 22 February 2021. The other $256,412 of transaction costs were costs 
settled via cash payments.

52  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21. Share-based payments

A performance right and share option plan has been established by the consolidated entity and approved by
shareholders at the 2017 Annual General Meeting, whereby the consolidated entity may, at the discretion of the
Board, performance rights and grant options over ordinary shares in the Company to certain key management
personnel of the consolidated entity. The performance rights and or options are issued for nil consideration and are
granted in accordance with performance guidelines established by the Board.

Set our below are summaries of Performance Rights and options granted under the plan:

2021 
Grant Date

21/11/2017

8/10/2018

8/10/2018

13/09/2019

19/09/2019

15/10/2019 

26/11/2019(1)

29/11/2019

12/06/2020

24/11/2020(1)

24/11/2020(2)

Exercise Price

Balance at the 
start of the year

Granted during 
the year

Expired/
forfeited/other

Balance at the 
end of the year

$0.030

$0.030

$0.030

$0.030

$0.030

$0.020

$0.030

$0.090

$0.060

$0.030

$0.030

6,800,000

6,800,000 

6,800,000 

360,507

3,425,000

2,400,000

14,377,766

7,188,883

1,700,000

-

-

-

-

-

-

-

-

-

-

22,500,000

3,400,000

-

-

-

(360,507)

(3,425,000)

(300,000)

(14,377,766)

6,800,000 

6,800,000 

6,800,000 

-

-

2,100,000

-

-

7,188,883

(1,700,000)

-

-

-

22,500,000

3,400,000

Weighted average exercise price

$0.04 

$0.03

$0.03

$0.04

49,852,156

25,900,000

(20,163,273)

55,588,883

1  22,500,000 options were issued to the Managing Director, Glenn Smith replacing the 14,377,766 options issued in 
2019.  Each option issued has an exercise price of $0.03 and will expire on the fifth anniversary of the date of issue.  
The options have the following vesting conditions:

• Execution of a market entry partnership agreement with a gross transaction value that has been defined by

the Board and agreed with the Managing Director pertaining to one of the following countries: China, India or
Indonesia; and

• Entry into a joint venture, licence or equivalent agreement with a gross transaction value that has been defined
by the Board and agreed with the Managing Director pertaining to one of the following countries: USA, UK or Japan.

2  Shareholder approval was given to the issue of 3,400,000 options to Director, David Brookes. These were issued 

with an exercise price of $0.03 and will expire on 21 November 2022. 

TALi Digital Limited Annual Report 2021  |  53

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

21. Share-based payments (continued)

2020 
Grant Date

3/10/2017

21/11/2017

8/10/2018

8/10/2018

13/09/2019

19/09/2019

15/10/2019 (1)

26/11/2019 (2)

29/11/2019 (3)

12/06/2020 (4)

Exercise 
Price

$0.030

$0.030

$0.030

$0.030

$0.030

$0.030

$0.020

$0.030

$0.090

$0.060

Granted 
during the 
year

Exercised 
during the 
year

Balance at 
the start of 
the year

14,377,766 

6,800,000 

6,800,000 

6,800,000 

-

-

-

-

-

-

-

-

-

-

360,507

3,425,000

2,400,000

14,377,766

7,188,883

1,700,000

34,777,766 

29,452,156 

Expired/
forfeited other

At the end 
of the year

(14,377,766)

- 

-

-

-

-

-

-

-

-

-

6,800,000 

6,800,000 

6,800,000 

360,507 

3,425,000 

2,400,000 

14,377,766 

7,188,883 

1,700,000 

(14,377,766)

49,852,156 

-

-

-

-

-

-

-

-

-

-

-

Weighted average exercise price

$0.03

$0.05

$0.00

$0.03

$0.04

1  Employee Options were issued under the shareholder approved Performance Right and Share Options Plan. The 
Options have the vesting dates of 31 October 2020 (740,000) 31 October 2021 (740,000) and 31 October 2022 
(960,000) and are subject to the employees remaining employees of the Group at vesting date. 

2  Employee Options were issued to the CEO in two tranches. 7,188,883 options (Tranche 1) will vest subject to the 

employee remaining an employee at vesting date, and the following clauses; 

• TD1 shares trade on the ASX at a minimum of $0.06 per Share for any consecutive 20 trading days during the

period from 3 October 2019 and until 3 October 2022, and

• TD1 achieving an operating profit for 2HFY20 (in the case that there are changes to the business plan approved

by the Board, the Board will determine in good faith any revision to the operating profit vesting criteria)

7,188,883 options (Tranche 2) will vest subject to the employee remaining an employee at vesting date, and the 
following clauses;

• TD1 shares trade on the ASX at a minimum of $0.09 per Share for any consecutive 20 trading days during the

period from 3 October 2019 and until 3 October 2022, and

• TD1 achieving an operating profit for 2HFY20 (in the case that there are changes to the business plan approved

by the Board, the Board will determine in good faith any revision to the operating profit vesting criteria)

3 Broker options issued vested upon issue.

4  Employee Options are issued under Performance Right and Share Options Plan. The Options vesting on 1 March 

2021 subject to meeting the Business Plan related KPIs.

54  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21. Share-based payments (continued)

The weighted average remaining contractual life of performance rights and options outstanding at the end of the
financial year was 2.63 years (2020: 2.37 years). 

For the options granted during the current financial year, the valuation model inputs used to determine the fair
value at the grant date are as follows:

Grant date

24/11/2020

24/11/2020

Expiry date

24/11/2025

24/11/2022

Share price  
at grant date 

$0.03

$0.03

Exercise price 

Expected volatility

$0.03

$0.03

137%

137%

TALi Digital Long-Term Incentive Plan

The purpose of the TALi Digital Long-Term Incentive Plan (LTIP) is to provide long term rewards that are linked 
to shareholder returns. Under the LTIP, selected executives may be offered several performance rights (Right) 
and share options. Each Right provides the entitlement to acquire one TALi share at nil cost to the satisfaction of 
performance hurdles. 

The fair value of performance rights granted is recognised as an employee expense with a corresponding increase 
in equity. The fair value is measured by an independent third party at grant date and recognised over the three-
year vesting period during which the employees become unconditionally entitled to the performance rights.

TALi Digital Limited Annual Report 2021  |  55

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

22. Notes to the statement of cash flows

For the year ended 30 June 2021

Cash as at the end of the financial year in the statement of cash flows 
is reconciled to the related items in the balance sheet as follows:

Cash at bank and on hand

Bank short term deposits

Cash assets (note 10)

Loss after income tax

Add: depreciation, amortisation and loss on disposal of plant and 
equipment

Share based payment expense

Investment (gain)/loss on revaluation and unrealised foreign 
exchange (gain)/loss

Total non-cash & non-operating items

(Increase)/decrease in receivables

(Increase)/decrease in other assets

(Increase)/decrease in employee benefits

(Increase)/decrease in deferred income

(Increase)/decrease in payables

Change in operating assets and other receivables

2021 
$

2020 
$

1,776,338 

148,058 

950,180 

3,797,350 

2,726,518 

3,945,408 

(4,858,273)

(3,397,938)

541,800

548,912

92,295

16,161

650,256

108,844

(1,987,124)

48,285

396,504

(156,538)

(1,590,029)

8,705

(68)

557,549

14,733

(24,887)

(27,807)

287,594

(127,182)

122,451

Net cash used in operating activities 

(5,798,046)

(2,717,938)

There have been no non-cash financing and investing transactions during the 2021 financial year (2020: nil) which 
have had a material effect on assets and liabilities of the Group.

56  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23. Financial instruments disclosure and financial risk management

The Group has exposure to market, credit and liquidity risks from the use of financial instruments. This note presents 
information about the Group’s exposure to each of these risks, its objectives, policies and processes for measuring 
and managing risk. The Board of Directors has overall responsibility for the establishment and oversight of the risk 
management framework.

Risk management policies are established to identify and analyse the risks faced by the Group, to set appropriate 
risk limits and controls, and to monitor risks and adherence to limits. The Group has adopted a Strategic Risk 
Management Framework through which it manages risks and aims to develop a disciplined and constructive 
control environment and action plans for risks that cannot be effectively managed through the use of controls. The 
Audit Committee oversees how management monitors compliance with the Group’s Strategic Risk Management 
Framework in relation to the changing risks faced by the Group.

(a) Market risk

Market risk is the risk that changes in market prices, such as foreign exchange rates, interest rates and equity 
prices, will affect the Group’s income or value of its holdings in financial instruments. The objective of market risk 
management is to manage and control market risk exposures within acceptable parameters, while optimising 
the financial return. No more than $2.7m of the Group’s cash resources is permitted to be invested in securities or 
investments other than bank and term deposits without approval by the shareholders at an AGM. In respect of listed 
company investments, the holding is reviewed by the Audit Committee if the market price falls by more than 10% 
below the initial acquisition cost. 

(i) Foreign currency risk 

The Group has contracts denominated in foreign currencies, predominantly in US dollars and Euros, and may enter 
into forward exchange contracts where appropriate in light of anticipated future purchases and sales, conditions 
in foreign markets, commitments from customers and past experience and in accordance with Board-approved 
limits. Note 3(e) sets out the accounting treatments for such contracts. There were no hedged amounts payable or 
receivable in foreign currencies at reporting date (2020: nil). 

At reporting date, the Group had the following exposures to foreign currency, converted to AUD:

Shares

Bank accounts

Payables

Gross balance sheet 
exposure

2021

2020

GBP

-

-

-

USD

1,370

5,823

7,193

SGD

EURO

GBP

-

-

-

-

-

-

-

-

USD

144

(29,437)

(29,293)

SGD

EURO

-

-

-

-

-

-

TALi Digital Limited Annual Report 2021  |  57

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

23. Financial instruments disclosure and financial risk management (continued)

Foreign currency sensitivity analysis

A 10% strengthening or weakening of the Australian dollar applied against the Gross balance sheet exposure
in the above table in respect of the above currencies at 30 June 2021 would have increased/(decreased) profit
or loss by the amounts shown below. This analysis assumes that all other variables, in particular interest rates,
remain constant. A sensitivity of 10% has been selected as this is considered reasonable taking in to account the
current level of exchange rates and the volatility observed both on a historical basis and on market expectations
for future movements. The analysis is performed on the same basis for 2020. There is no impact on equity.

2021 Exposure

Equity

Profit and loss

Strengthening

Weakening

Strengthening

Weakening

Gross balance sheet exposure

-

-

541

(492)

2020 Exposure

Equity

Profit and loss

Strengthening

Weakening

Strengthening

Weakening

Gross balance sheet exposure

-

-

2,041

(1,856)

The following significant exchange rates applied during the financial year:

Currency 

GBP

USD

EURO

Average rate

Reporting date spot rate

2021

0.55

0.72

0.63

2020

0.56

0.70

0.62

2021

0.54

0.75

0.63

2020

0.56

0.69

0.62

(ii) Interest rate risk

Interest earned on cash at bank is determined in accordance with published bank interest rates. The Group’s 
exposure to interest rate risk is confined to cash assets, the effective weighted average interest rate for which is set 
out below.

Financial assets

Cash assets – at 30 June 2021

Cash assets – at 30 June 2020

Financial liabilities

Borrowings – at 30 June 2021

Borrowings – at 30 June 2020

Effective  
interest rate  
%

Floating  
interest rate 
$

3 months  
or less 
$

Non-interest 
bearing 
$

Total 
$

0.01

0.46

950,180

3,797,450

-

-

-

-

-

-

-

-

1,776,338

148,058

-

-

-

-

-

-

58  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Profit and loss

Profit and loss

Cash at bank – 
variable interest rate: 
$AUD

2021

2020

Strengthening

Weakening

Strengthening

Weakening

4,751

(4,751)

18,987

(18,987)

An increase or decrease of 0.50% in interest rates applied for 12 months to the cash balances at reporting date 
would have increased or decreased profit or loss by $4,751 (2020: $18,987), if all other variables, including foreign 
currency rates, remain constant. The analysis is performed on the same basis for 2020.

(b) Credit risk

Credit risk represents the loss that would be recognised if counterparties fail to perform as contracted. For financial 
assets, the credit risk exposure of the Group is the carrying amount of the asset net of any provision for expected 
credit losses. For the Group, from interest and capital on deposits with financial institutions.

(i) Investments (including cash)

The Group’s Cash Management and Treasury Policy limits the maximum proportion of TALi Digital’s aggregate 
gross cash resources that can be placed with or invested in any one counterparty, having regard to the credit risk 
assigned to that counterparty unless the Board determines otherwise. No more than $2.7 million of the Group’s cash 
resources permitted to be invested in securities or investments other than bank and term deposits without approval 
by the shareholders at an AGM. In respect of listed company investments, the holding is reviewed by the Audit 
Committee if the market price falls by more than 10% below the initial acquisition cost. 

(ii) Receivables 

The Group undertakes due diligence prior to entering any collaboration, co-development or licensing agreement 
with a counterparty that exposes the Group to credit risk. The Group’s exposure to credit risk from receivables is 
shown below. No amounts are past due and impaired at balance date.

Financial assets

3 months or less 
$

Greater than 3 
months  
$

Greater than 1 
year  
$

Receivables – at 30 June 2021

Receivables – at 30 June 2020

652,139

953,317

-

-

-

2,750

Total 
$

652,139

956,067

(c) Liquidity risk

Liquidity risk is the risk that the Group will not be able to meet its financial obligations as and when they fall 
due. The Group’s approach to managing liquidity is to ensure that it will maintain sufficient liquidity to meet its 
liabilities when due having regard to forecast cash inflows and outflows, which in turn may be impacted by 
planned corporate transactions.

The Group has no lines of credit other than a Bank Guarantee of $100,000. The Group manages its liquidity risk 
using existing cash reserves managed in accordance with a Cash Management and Treasury Policy. Under this 
policy, sufficient liquidity to meet day to day operating requirements is maintained in interest-bearing operating, 
at-call and term bank accounts. Cash balances are prepared daily and cash requirements monitored on 
weekly, month end reporting and annual budget/forecast cycles.

TALi Digital Limited Annual Report 2021  |  59

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

23. Financial instruments disclosure and financial risk management (continued)

(c) Liquidity risk

At reporting date, the Group had the following financial liability exposures:

Financial liabilities

Creditors – at 30 June 2021

Creditors – at 30 June 2020

Financial liabilities

3 months or less 
$

Greater than 3 
months 
$

Greater than 1 
year 
$

100,010

819,924

-

9,014

-

-

Less than one 
year 
$

One to five years 
$

More than 5 
years 
$

Lease liabilities – at 30 June 2021

Lease liabilities – at 30 June 2020

56,487

143,412

-

55,661

-

-

Maturity analysis – contractual undiscounted 
cash flows on lease liabilities

122,514

Less than one year

One to five years

Total undiscounted lease liability at 30 June

Other disclosures

Interest expenses on lease liabilities recognised in the profit or loss

Total cash outflow for leases recognised in the statement of cashflows

2021 
$

56,487

-

56,487

7,050

137,073

Total 
$

100,010

828,938

Total 
$

56,487

199,073

2020 
$

143,412

55,661

199,073

15,097

122,514

(d) Net fair values of financial assets and liabilities

(i)  For monetary financial assets and financial liabilities not readily traded in an organised financial market, values
are determined by valuing them at the value of contractual cash flow amounts due from customers and payable
to suppliers discounted as appropriate for settlements beyond 12 months;

(ii)  The carrying amounts of bank balances and deposits, trade debtors and accounts payable expected to be

payable within 12 months.

At reporting date there were no material differences between carrying values and fair values.

(e) Capital management

The Board’s policy is to maintain a sufficient capital base so as to sustain investor, creditor and market confidence 
and to facilitate the future development of the business. As noted in note 2(b), in order to meet forecast operating 
cash requirements, the Group may need to raise funds from other sources which may include raising capital or 
securing debt facilities.

60  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24. Dividends

There were no dividends paid, recommended or declared during the current or previous financial year.

25. Dividend franking account

The Company has no franking credits at reporting date.

26. Auditors’ remuneration

Audit services:

Auditors of the Group – RSM

Auditors of the Group – Grant Thornton

Total audit services

Other services:

Tax compliance and advisory services – RSM

Tax compliance and advisory services Group – Grant Thornton

Total other services

27. Segmented reporting

From 1 July 2020 the Group deemed that it has only one business segment.

2021 
$

-

68,210

68,210

-

-

-

2020 
$

23,250

60,000

83,250

7,400

13,000

20,400

28. Related party transactions

Disclosures of compensation policies, service contracts and details of individual directors and executive’s 
compensation are included in the Remuneration Report section of the Directors’ Report.

Directors and Key Management Personnel compensation

The Directors and Key Management Personnel compensation included in “employee expenses” are as follows:

Nature of compensation

Short-term employee benefits

Performance benefits

Post-employment benefits

Share-based payments

Total compensation

2021 
$

371,751

93,750

31,992

90,891

588,384

2020 
$

374,483

62,500

30,933

-

467,916

Key Management Personnel transactions

Directors of the Company control 4.68% (2020: 5.83%) of the voting shares of the Company.

Several key management personnel, or their related parties, hold positions in other companies that result in them 
having control or significant influence over these companies. However, during the period the Group did not transact 
with any of these companies.

Other Key Management Personnel transactions with the Group

No Key Management Personnel member has entered a material contract with the Group during either the 2021 or 
2020 financial years and there were no material contracts with, amounts receivable from or payable to, interests 
involving directors or executives at period end. The value of transactions during the year with entities related to 
Directors included in the financial statements was nil (2020: nil).

TALi Digital Limited Annual Report 2021  |  61

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Financial Statements continued

FOR THE YEAR ENDED 30 JUNE 2021

28. Related party transactions (continued)

Other Key Management Personnel transactions with the Group

There are no outstanding balances at the reporting date in relation to transactions with related parties other than
KMPs: No provision for doubtful debts has been raised against amounts receivable from other related parties.

Loans and other transactions with Key Management Personnel

There were no loans made to Directors or Executives or other loan movements during the 2021 year.

Other related party transactions

Other than the transactions disclosed above, there were no transactions with other related parties during either the
2021 or 2020 financial years.

29. Group entities

Significant subsidiaries for the year ended:

Name

Country of incorporation

Ownership interest %

TALi Health Pty Ltd

ACN 158 797 936 Pty Ltd1

TALi Digital INC

Australia

Australia

USA

TALi Digital (UK) Limited

United Kingdom

1ACN 158 797 936 Pty Ltd was de-registered on 14/09/2020.

2021

100

-

100

100

2020

100

100

100

100

30. Parent entity disclosure

As at, and throughout, the financial year ended 30 June 2021, the parent entity of the Group was TALi Digital Limited.

Statement of profit and loss

Loss after income tax

Total comprehensive (loss)/income

Statement of financial position

Total current assets

Total assets

Total current liabilities

Total liabilities

Net assets

Equity

Issued capital

Change in fair value reserve

Share-based payments reserve

Accumulated losses

Total equity

62  |  TALi Digital Limited Annual Report 2021

2021 
$

2020 
$

(2,442,426)

(1,090,531)

(2,442,426)

(1,090,531)

12,845,625

8,798,017

13,300,179

9,542,092

416,608

1,085,555

1,821,484

2,068,734

11,478,695

7,473,358

208,157,446

202,096,875

(1,000,000)

(1,000,000)

1,502,351

1,098,238

(197,181,102)

(194,721,755)

11,478,695

7,473,358

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31. Commitments

The Company has no commitments at year end.

32. Contingent liabilities

The Group is not aware of any contingent liabilities or contingent assets capable of having a material impact 
on the Group.

33. Events after the reporting period

On 20 July 2021, 6,000,000 options were issued to employees under the employee incentive scheme:

(i) 2,000,000 options exercisable at $0.06, vesting on 1 July 2022 with an expiry date of 30 June 2026.

(ii) 2,000,000 options exercisable at $0.09, vesting on 1 July 2023 with an expiry date of 30 June 2026.

(iii) 2,000,000 options exercisable at $0.09, vesting on 1 July 2024 with an expiry date of 30 June 2026.

On 20 July 2021, 900,000 options previously issued to employees were cancelled.

On 18 August 2021, the Company announced it had entered into a Strategic Licensing Agreement (Agreement) 
with Akili Interactive Labs, Inc., a global leader in the digital therapeutics space. Under the Agreement, the 
Company will receive total milestone payments of up A$51 million (US$37.5 million) as well as royalties on future 
sales.

On 28 September 2021 the Company received the FY21 income tax return refund of $795,873 in relation to the 
Research & Development Tax Incentive.

In the interval between the end of the financial year and the date of this report no other item, transaction 
or event of a material and unusual nature has arisen other than outlined in this section that is likely, in the 
opinion of the directors of the Company, to affect significantly the operations of the Group, the results of those 
operations, or the state of affairs of the Group in future financial years.

TALi Digital Limited Annual Report 2021  |  63

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Declaration

FOR THE YEAR ENDED 30 JUNE 2021

In the opinion of the directors of TALi Digital Limited (‘the Company’):

• The attached financial statements and notes comply with the Corporations Act 2001, the Accounting Standards,

the Corporations Regulations 2001 and other mandatory professional reporting requirements;

• The attached financial statements and notes comply with International Financial Reporting Standards as issued

by the International Accounting Standards Board as described in note 3 to the financial statements;

• The attached financial statements and notes give a true and fair view of the Group’s financial position as at 30

June 2021 and of its performance for the financial year ended on that date; and

• There are reasonable grounds to believe that the company will be able to pay its debts as and when they

become due and payable.

The directors have been given the declarations required by section 295A of the Corporations Act 2001.

Signed in accordance with a resolution of directors made pursuant to section 295(5)(a) of the Corporations Act 2001.

On behalf of the directors

Sue MacLeman 
Chair

Dated at Melbourne this 30th of September 2021.

64  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TALi Digital Limited Annual Report 2021  |  65
TALi Digital Limited Annual Report 2021  |  65
TALi Digital Limited Annual Report 2021  |  65

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collins Square, Tower 5 
727 Collins Street 
Melbourne VIC 3000 

Correspondence to: 
GPO Box 4736 
Melbourne VIC 3001 

T +61 3 8320 2222 
F +61 3 8329 2200 
E info.vic@au.gt.com 
W www.grantthornton.com.au  

Independent Auditor’s Report 

To the Members of TALi Digital Limited 

Report on the audit of the financial report 

Opinion 

We have audited the financial report of TALi Digital Limited (the Company) and its subsidiaries (the Group), which 
comprises the consolidated statement of financial position as at 30 June 2021, the consolidated statement of profit or loss 
and other comprehensive income, consolidated statement of changes in equity and consolidated statement of cash flows 
for the year then ended, and notes to the consolidated financial statements, including a summary of significant accounting 
policies, and the Directors’ declaration. 

In our opinion, the accompanying financial report of the Group is in accordance with the Corporations Act 2001, including: 

a  giving a true and fair view of the Group’s financial position as at 30 June 2021 and of its performance for the year 

ended on that date; and 

b  complying with Australian Accounting Standards and the Corporations Regulations 2001. 

Basis for opinion 

We conducted our audit in accordance with Australian Auditing Standards. Our responsibilities under those standards are 
further described in the Auditor’s Responsibilities for the Audit of the Financial Report section of our report. We are 
independent of the Group in accordance with the auditor independence requirements of the Corporations Act 2001 and 
the ethical requirements of the Accounting Professional and Ethical Standards Board’s APES 110 Code of Ethics for 
Professional Accountants (the Code) that are relevant to our audit of the financial report in Australia. We have also fulfilled 
our other ethical responsibilities in accordance with the Code. 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

Material uncertainty related to going concern 

We draw attention to Note 2(b) in the financial statements, which indicates that the Group incurred a net loss of $4,858,273 
during the year ended 30 June 2021, and for the period ended on this date, the Group’s operating cash flow for the year was 
an outflow of $5,798,046. There also remains significant uncertainty around the breadth and duration of government policy and 
regulations governing individuals and businesses due to COVID-19. As stated in Note 2(b), these events or conditions indicate 
that a material uncertainty exists that may cast doubt on the Group’s ability to continue as a going concern. Our opinion is not 
modified in respect of this matter. 

Grant Thornton Audit Pty Ltd ACN 130 913 594 
a subsidiary or related entity of Grant Thornton Australia Ltd ABN 41 127 556 389 

www.grantthornton.com.au 

‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients 
and/or refers to one or more member firms, as the context requires. Grant Thornton Australia Ltd is a member firm of Grant Thornton International 
Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are 
delivered by the member firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate one 
another and are not liable for one another’s acts or omissions. In the Australian context only, the use of the term ‘Grant Thornton’ may refer to 
Grant Thornton Australia Limited ABN 41 127 556 389 and its Australian subsidiaries and related entities. GTIL is not an Australian related entity to 
Grant Thornton Australia Limited. 

Liability limited by a scheme approved under Professional Standards Legislation. 

66   |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key audit matters 

Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the financial 
report of the current period. These matters were addressed in the context of our audit of the financial report as a whole, and in 
forming our opinion thereon, and we do not provide a separate opinion on these matters.  

In addition to the matter described in the Material uncertainty related to going concern section, we have determined the 
matters described below to be the key audit matters to be communicated in our report. 

Key audit matter 

How our audit addressed the key audit matter 

Intangible Assets – note 14 

The Group has intangible assets with a written down value of 
$4,126,199 as at 30 June 2021, which consist of both 
acquired intangibles and internally generated intangibles. 

The acquired assets consist of a health license and intellectual 
property relating to the TALi technology acquired as part of the 
purchase of TALi Health Pty Ltd in 2016. Internally generated 
intangibles consists of capitalised development costs relating 
to the TALI Train and TALi Detect products which the Group 
has developed. 

In accordance with AASB 138 Intangible Assets only directly 
attributable costs incurred during the development phase may 
be capitalised and recognised as an asset. AASB 136 
Impairment of Assets requires that an entity shall assess at 
the end of each reporting period whether there is any 
indication that an asset may be impaired. If any indication 
exists, the entity shall estimate the recoverable amount of the 
asset. 

This area is a key audit matter due to the level of judgement 
and estimation required in determining the recoverable 
amounts and recognition of R&D and whether the 
requirements of AASB 138 and AASB 136 are satisfied. 

Our procedures included, amongst others: 

• Assessing the company's accounting policy for capitalisation of

development costs for adherence to AASB 138;

• Agreeing a sample of additions to supporting documents such
as time records or invoices from third party suppliers and
assessing whether the amounts met the recognition criteria in
AASB 138;

• Evaluating the assumptions utilised by management which
support the generation of future economic benefits from the
capitalised costs;

• Considering other qualitative considerations (e.g. market

valuation of the company compared to its net assets, recent
trial results, other public information available or press
releases) in order to challenge management’s assessment of
impairment indicators;

• Assessing the change in estimate for useful life of intangible

products made by management during the period;

• Obtaining supporting documentation to demonstrate ongoing

use of the asset; and

• Assessing the adequacy of the disclosures within the financial

statements.

R&D Incentives – note 11 

The Group received a 43.5% refundable tax offset of eligible 
expenditure under the Research and Development (R&D) Tax 
Incentive scheme if its turnover is less than $20 million per 
annum, provided it is not controlled by income tax exempt 
entities. 

An R&D plan is filed with AusIndustry in the following financial 
year, and based on this filing, the Group receives the incentive 
in cash. Management has performed a detailed review of the 
Group’s total research and development expenditure to 
determine the potential claim under the R&D tax incentive 
legislation. 

The process in calculating the R&D tax rebate requires 
judgment and specialised knowledge in identifying eligible 
expenditure which give rise to anticipated R&D tax incentives. 
Balances in relation to R&D tax incentives are therefore 
considered to be a key focus area as part of our audit. 

Our procedures included, amongst others: 

• Comparing the estimates made in prior year to the amount of

cash received after lodgement of the R&D tax claim;

• Utilising an internal R&D tax specialist to review the

expenditure methodology employed by management;

• Obtaining FY20 R&D rebate calculations performed by

management and performing the following audit procedures:

–

–

–

–

Developing an understanding of the model, identifying
and assessing key assumptions in the calculation;

Verifying included expenses agree to the underlying
supporting documentation;

Testing the mathematical accuracy of the accrual; and

Considering the nature of the expenses against the
eligibility criteria of the R&D tax incentive scheme to form
a view about whether the expenses included in the
estimate were likely to meet the eligibility criteria.

• Reviewing disclosures in the notes to the financial statements

to ensure adequacy.

TALi Digital Limited Annual Report 2021  |  67

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Information other than the financial report and auditor’s report thereon 

The Directors are responsible for the other information. The other information comprises the information included in the 
Group’s annual report for the year ended 30 June 2021, but does not include the financial report and our auditor’s report 
thereon.  

Our opinion on the financial report does not cover the other information and we do not express any form of assurance 
conclusion thereon.  

In connection with our audit of the financial report, our responsibility is to read the other information and, in doing so, consider 
whether the other information is materially inconsistent with the financial report or our knowledge obtained in the audit or 
otherwise appears to be materially misstated.  

If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are 
required to report that fact. We have nothing to report in this regard.  

Responsibilities of the Directors for the financial report 

The Directors of the Company are responsible for the preparation of the financial report that gives a true and fair view in 
accordance with Australian Accounting Standards and the Corporations Act 2001 and for such internal control as the Directors 
determine is necessary to enable the preparation of the financial report that gives a true and fair view and is free from material 
misstatement, whether due to fraud or error.  

In preparing the financial report, the Directors are responsible for assessing the Group’s ability to continue as a going concern, 
disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the 
Directors either intend to liquidate the Group or to cease operations, or have no realistic alternative but to do so.  

Auditor’s responsibilities for the audit of the financial report 

Our objectives are to obtain reasonable assurance about whether the financial report as a whole is free from material 
misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance 
is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Australian Auditing 
Standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are 
considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions 
of users taken on the basis of this financial report.  

A further description of our responsibilities for the audit of the financial report is located at the Auditing and Assurance 
Standards Board website at: http://www.auasb.gov.au/auditors_responsibilities/ar1.pdf. This description forms part of our 
auditor’s report 

Report on the remuneration report 

Opinion on the remuneration report 

We have audited the Remuneration Report included in pages 17 to 26 of the Directors’ report for the year ended 
30 June 2021. 

In our opinion, the Remuneration Report of TALi Digital Limited, for the year ended 30 June 2021 complies with section 
300A of the Corporations Act 2001. 

68   |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Responsibilities 

The Directors of the Company are responsible for the preparation and presentation of the Remuneration Report in accordance 
with section 300A of the Corporations Act 2001. Our responsibility is to express an opinion on the Remuneration Report, 
based on our audit conducted in accordance with Australian Auditing Standards.  

Grant Thornton Audit Pty Ltd 
Chartered Accountants 

M A Cunningham 
Partner – Audit & Assurance 

Melbourne, 30 September 2021 

TALi Digital Limited Annual Report 2021  |  69

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shareholder Information

Share capital

The shareholder information set out below was applicable as at 25 August 2021.

Number

Number of shares quoted on the Australian Securities Exchange Limited 931,905,789.

TALi Digital Limited ordinary shares have been traded on ASX Limited since 28th December 2019 (former name Novita 
Healthcare Limited) and trade under the ASX code TD1. Melbourne is the Home Exchange. The Company’s securities 
are not quoted on any other stock exchange.

Position Holder name

Holding

BNP PARIBAS NOMINEES PTY LTD 

66,494,118

GREY INNOVATION HOLDINGS PTY LTD

SAILORS OF SAMUI PTY LTD

30,909,488

24,305,455

MONDO ELECTRONICS PTY LTD 

19,884,346

BNP PARIBAS NOMINEES PTY LTD HUB24 CUSTODIAL SERV LTD 

MOONAH CAPITAL PTY LTD

JP MORGAN NOMINEES AUSTRALIA PTY LIMITED

KEMBLA NO 20 PTY LTD 

SANLAM PRIVATE WEALTH PTY LTD 

HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED

TEN GOALS PTY LTD 

MR DONAL FRANCIS O’SULLIVAN

PUNTERO PTY LTD

MRS SHWETA PRIYADARSHINI

ENJIRU PTY LTD 

17,701,984

16,000,000

15,425,505

14,300,000

12,500,000

10,222,898

10,000,000

10,000,000

10,000,000

9,850,000

9,044,204

CPO SUPERANNUATION FUND PTY LTD 

7,954,271

MR CARMELO CANNAVO

MR ALAN CONIGRAVE

PETERLYN PTY LTD 

TEEFISH SUPER PTY LTD 

JMT INVESTMENT GROUP VIC PTY LTD

CITOS SUPER PTY LTD 

CITICORP NOMINEES PTY LIMITED

CORWEST PTY LTD

Totals

Total issued capital

7,320,000

7,200,000

7,200,000

7,100,000

7,000,000

7,000,000

6,881,979

6,415,560

340,709,808

931,905,789

36.56%

100.00%

70  |  TALi Digital Limited Annual Report 2021

% IC

7.14%

3.32%

2.61%

2.13%

1.90%

1.72%

1.66%

1.53%

1.34%

1.10%

1.07%

1.07%

1.07%

1.06%

0.97%

0.85%

0.79%

0.77%

0.77%

0.76%

0.75%

0.75%

0.74%

0.69%

1

2

3

4

5

6

7

8

9

10

11

11

11

12

13

14

15

16

16

17

18

18

19

20

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distribution of shareholders as at 25 August 2021

Holding ranges

Holders

Total units

% Issued share capital 

Above 0 up to and including 1,000

Above 1,000 up to and including 5,000

Above 5,000 up to and including 10,000

Above 10,000 up to and including 100,000

Above 100,000

Totals

375

212

200

1,140

797

2,724

105,134

603,727

1,646,859

46,780,256

882,769,813

931,905,789

0.01%

0.06%

0.18%

5.02%

94.73%

100.00%

The number of shareholders as at 25 August 2021 with less than a marketable parcel of $500 worth of shares, based 
on the market price as at that date ($0.038 per share), was 901, with total 3,657,268 amounting to 0.39% of Total 
Shareholding.

Corporate Governance Statement

In accordance with ASX Listing Rule 4.10.3 the Company’s 2021 Corporate Governance Statement can be found at 
https://talidigital.com/investors-centre/governance/

Voting rights

The voting rights attached to ordinary shares are set out in Rule 5(f) and 40 of the Company’s Constitution. In broad 
summary, but without prejudice to the provisions of those Rules, each shareholder present at a general meeting in 
person or by duly appointed representative, proxy or attorney.

(a)  On a show of hands, has one vote except if a shareholder has appointed more than one person as a

representative, proxy or attorney, in which care none of those persons is entitled to vote or if a person is entitled
to vote in more than one capacity, that person is entitled to only one vote; and

(b)  On a poll, has one vote for each fully paid share held and for each other share held, has a vote in respect of the
share equivalent to the proportion that the amount paid on that share is of the total amounts paid and payable
on that share at the time a poll is taken but no amount paid on a share in advance of calls shall be treated as
paid on that share.

As at 25 August 2021, the Options issued over unissued Ordinary Shares totalled 60,688,883 represented by 7,200,000 
granted to employees under the ESOP, 36,100,000 issued to Directors, and 17,388,883 issued to external suppliers for 
services rendered. There are no voting rights attached to either the Options or the underlying unissued Ordinary Shares.

Issued capital report as at 25 August 2021

Security 
code

Security 
name

CHESS 
holders

CHESS 
holdings

 % CHESS 
holdings

Issuer 
holders

Issuer 
holdings

% Issuer 
holdings

Total 
holders

TD1

Ordinary 
fully paid 
shares

2,466

903,794,155

96.98%

258

28,111,634

3.02%

2,724

TALi Digital Limited Annual Report 2021  |  71

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shareholder Information continued

Officers

Managing Director: Glenn Smith

Company Secretary: Stephen Denaro 

Registered Office

TALi Digital Limited 

Level 5, 19 William Street 

Share Registry

Automic Registry Services 

Level 3, 50 Holt Street 

Cremorne, Victoria 3121 Australia

Surry Hills, New South Wales 2010 Australia

Telephone 

+61 3 9192 9937   |   1300 082 013

Telephone 

1300 288 664

Website 

talidigital.com

Website 

automic.com.au

Email 

info@talidigital.com.au

Email 

hello@automic.com.au

Securityholder Information

You can gain access to your security holding information in a number of ways. The details are managed via 
the Company’s Registrar, Automic Registry Services, and can be accessed as outlined below. Please note your 
Securityholder Reference Number (SRN) or Holder Identification Number (HIN) is required for access.

Investor Phone Access

Provides telephone access, call 1300 288 664 to speak to an operator.

Internet Account Access

Securityholders can access their details via the internet. Automic provides access via its InvestorShare online 
service. Go to investor.automic.com.au to view your information.

Changing Shareholder Details

Changes to your name or address must be advised in writing to Automic Registry Services. If you are sponsored by a 
broker, your notice in writing must be sent to your sponsoring broker.

TALi Digital Limited Publications Mailing List

The Annual Report is a major source of information about the Company. Shareholders who do not wish to receive 
this publication can assist the Company to reduce costs by advising Automic Registry Services in writing or doing so 
online using http://investor.automic.com.au/#/home. Shareholders will continue to receive all other shareholder 
information, including the Notice of Annual General Meeting and Proxy Form. The Annual Report. Other releases 
and general Company information are also available on the Company’s website at www.talidigital.com.au

Investor Relations

If you have any questions or issues regarding your shareholding, please contact Automic Registry Services 
on 1300 288 664.

72  |  TALi Digital Limited Annual Report 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TALi Digital Limited

ABN 53 108 150 750

Level 5, 19 William Street 
Cremorne, Victoria 3121 Australia

T +61 3 9192 9937   |   1300 082 013

talidigital.com.au